ZA200309590B - Thiophene derivatives as antiviral agents for flavivirus infection. - Google Patents
Thiophene derivatives as antiviral agents for flavivirus infection. Download PDFInfo
- Publication number
- ZA200309590B ZA200309590B ZA200309590A ZA200309590A ZA200309590B ZA 200309590 B ZA200309590 B ZA 200309590B ZA 200309590 A ZA200309590 A ZA 200309590A ZA 200309590 A ZA200309590 A ZA 200309590A ZA 200309590 B ZA200309590 B ZA 200309590B
- Authority
- ZA
- South Africa
- Prior art keywords
- carboxylic acid
- phenyl
- thiophene
- acid compound
- amino
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title claims description 9
- 206010054261 Flavivirus infection Diseases 0.000 title description 3
- 150000003577 thiophenes Chemical class 0.000 title 1
- -1 2- phenylethenyl Chemical group 0.000 claims description 1036
- 150000001875 compounds Chemical class 0.000 claims description 313
- 125000000217 alkyl group Chemical group 0.000 claims description 161
- 125000000623 heterocyclic group Chemical group 0.000 claims description 133
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 105
- 229910052739 hydrogen Inorganic materials 0.000 claims description 104
- 125000000304 alkynyl group Chemical group 0.000 claims description 103
- 125000003342 alkenyl group Chemical group 0.000 claims description 101
- 125000003118 aryl group Chemical group 0.000 claims description 100
- 229910052799 carbon Inorganic materials 0.000 claims description 79
- 125000004475 heteroaralkyl group Chemical group 0.000 claims description 47
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 45
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 38
- 229910052736 halogen Inorganic materials 0.000 claims description 38
- 150000002367 halogens Chemical class 0.000 claims description 38
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims description 24
- 125000001544 thienyl group Chemical group 0.000 claims description 23
- 230000003612 virological effect Effects 0.000 claims description 23
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 20
- 229910052757 nitrogen Inorganic materials 0.000 claims description 20
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 15
- 125000003545 alkoxy group Chemical group 0.000 claims description 12
- 125000001424 substituent group Chemical group 0.000 claims description 12
- LMYRWZFENFIFIT-UHFFFAOYSA-N toluene-4-sulfonamide Chemical group CC1=CC=C(S(N)(=O)=O)C=C1 LMYRWZFENFIFIT-UHFFFAOYSA-N 0.000 claims description 12
- 125000004076 pyridyl group Chemical group 0.000 claims description 11
- 150000003536 tetrazoles Chemical class 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 10
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 9
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 9
- KXDAEFPNCMNJSK-UHFFFAOYSA-N Benzamide Chemical group NC(=O)C1=CC=CC=C1 KXDAEFPNCMNJSK-UHFFFAOYSA-N 0.000 claims description 8
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 8
- 125000004104 aryloxy group Chemical group 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 7
- 125000005133 alkynyloxy group Chemical group 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 125000000018 nitroso group Chemical group N(=O)* 0.000 claims description 7
- 239000008194 pharmaceutical composition Substances 0.000 claims description 7
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 7
- 238000011282 treatment Methods 0.000 claims description 7
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 6
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims description 6
- 108060004795 Methyltransferase Proteins 0.000 claims description 6
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 6
- 125000000842 isoxazolyl group Chemical group 0.000 claims description 6
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims description 6
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 claims description 5
- 208000036142 Viral infection Diseases 0.000 claims description 5
- 125000004196 benzothienyl group Chemical group S1C(=CC2=C1C=CC=C2)* 0.000 claims description 5
- 125000002541 furyl group Chemical group 0.000 claims description 5
- 125000001041 indolyl group Chemical group 0.000 claims description 5
- 229960000329 ribavirin Drugs 0.000 claims description 5
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 claims description 5
- 230000009385 viral infection Effects 0.000 claims description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 125000000499 benzofuranyl group Chemical group O1C(=CC2=C1C=CC=C2)* 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 4
- 150000001805 chlorine compounds Chemical class 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 208000015181 infectious disease Diseases 0.000 claims description 4
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims description 4
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 229910052717 sulfur Inorganic materials 0.000 claims description 4
- 125000000335 thiazolyl group Chemical group 0.000 claims description 4
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims description 3
- 241000710781 Flaviviridae Species 0.000 claims description 3
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 claims description 3
- 125000002047 benzodioxolyl group Chemical group O1OC(C2=C1C=CC=C2)* 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 3
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 230000002265 prevention Effects 0.000 claims description 3
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 3
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 3
- HJOOKKDLEJXVSI-UHFFFAOYSA-N 4-chloro-2,6-dimethylbenzenesulfonamide Chemical group CC1=CC(Cl)=CC(C)=C1S(N)(=O)=O HJOOKKDLEJXVSI-UHFFFAOYSA-N 0.000 claims description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 2
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 claims 36
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 25
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 20
- 239000003795 chemical substances by application Substances 0.000 claims 20
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Divinylene sulfide Natural products C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 claims 16
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims 13
- 229940015849 thiophene Drugs 0.000 claims 12
- 229930192474 thiophene Natural products 0.000 claims 11
- CIEWGZJDEDBECJ-UHFFFAOYSA-N 1-chloro-4-methylbenzene Chemical class [CH2]C1=CC=C(Cl)C=C1 CIEWGZJDEDBECJ-UHFFFAOYSA-N 0.000 claims 10
- QGMFBCDNJUZQBZ-UHFFFAOYSA-N 5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=CC=C1 QGMFBCDNJUZQBZ-UHFFFAOYSA-N 0.000 claims 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 9
- AVRWEULSKHQETA-UHFFFAOYSA-N Thiophene-2 Chemical compound S1C=2CCCCCC=2C(C(=O)OC)=C1NC(=O)C1=C(F)C(F)=C(F)C(F)=C1F AVRWEULSKHQETA-UHFFFAOYSA-N 0.000 claims 8
- 239000002253 acid Substances 0.000 claims 8
- NKLCHDQGUHMCGL-UHFFFAOYSA-N cyclohexylidenemethanone Chemical class O=C=C1CCCCC1 NKLCHDQGUHMCGL-UHFFFAOYSA-N 0.000 claims 8
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 claims 7
- GEAXLHPORCRESC-UHFFFAOYSA-N chlorocyclohexatriene Chemical class ClC1=CC=C=C[CH]1 GEAXLHPORCRESC-UHFFFAOYSA-N 0.000 claims 7
- 229920002554 vinyl polymer Polymers 0.000 claims 7
- SLRMQYXOBQWXCR-UHFFFAOYSA-N 2154-56-5 Chemical class [CH2]C1=CC=CC=C1 SLRMQYXOBQWXCR-UHFFFAOYSA-N 0.000 claims 6
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims 6
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 6
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims 5
- KWWGBNRBZMJKPA-UHFFFAOYSA-N 3-phenylthiophene-2-carboxylic acid Chemical compound S1C=CC(C=2C=CC=CC=2)=C1C(=O)O KWWGBNRBZMJKPA-UHFFFAOYSA-N 0.000 claims 4
- 229940121759 Helicase inhibitor Drugs 0.000 claims 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 claims 4
- ZHCAAFJSYLFLPX-UHFFFAOYSA-N nitrocyclohexatriene Chemical class [O-][N+](=O)C1=CC=C=C[CH]1 ZHCAAFJSYLFLPX-UHFFFAOYSA-N 0.000 claims 4
- FBBNCVURFSVLFJ-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC=C1 FBBNCVURFSVLFJ-UHFFFAOYSA-N 0.000 claims 3
- 102000053642 Catalytic RNA Human genes 0.000 claims 3
- 108090000994 Catalytic RNA Proteins 0.000 claims 3
- PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 claims 3
- 229930105110 Cyclosporin A Natural products 0.000 claims 3
- 108010036949 Cyclosporine Proteins 0.000 claims 3
- 102000014150 Interferons Human genes 0.000 claims 3
- 108010050904 Interferons Proteins 0.000 claims 3
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims 3
- 229940123066 Polymerase inhibitor Drugs 0.000 claims 3
- 229940122055 Serine protease inhibitor Drugs 0.000 claims 3
- 101710102218 Serine protease inhibitor Proteins 0.000 claims 3
- 244000272459 Silybum marianum Species 0.000 claims 3
- 235000010841 Silybum marianum Nutrition 0.000 claims 3
- 102000007501 Thymosin Human genes 0.000 claims 3
- 108010046075 Thymosin Proteins 0.000 claims 3
- 229960004308 acetylcysteine Drugs 0.000 claims 3
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 claims 3
- 229960003805 amantadine Drugs 0.000 claims 3
- 239000003242 anti bacterial agent Substances 0.000 claims 3
- 230000000692 anti-sense effect Effects 0.000 claims 3
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 claims 3
- 229960001265 ciclosporin Drugs 0.000 claims 3
- 229930182912 cyclosporin Natural products 0.000 claims 3
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 claims 3
- 229940079322 interferon Drugs 0.000 claims 3
- GPKUICFDWYEPTK-UHFFFAOYSA-N methoxycyclohexatriene Chemical class COC1=CC=C=C[CH]1 GPKUICFDWYEPTK-UHFFFAOYSA-N 0.000 claims 3
- 125000004193 piperazinyl group Chemical group 0.000 claims 3
- 108091092562 ribozyme Proteins 0.000 claims 3
- 239000003001 serine protease inhibitor Substances 0.000 claims 3
- LCJVIYPJPCBWKS-NXPQJCNCSA-N thymosin Chemical compound SC[C@@H](N)C(=O)N[C@H](CO)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CO)C(=O)N[C@H](CO)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@H]([C@H](C)O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCCCN)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](C(C)C)C(=O)N[C@H](C(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@H](CCC(O)=O)C(O)=O LCJVIYPJPCBWKS-NXPQJCNCSA-N 0.000 claims 3
- UAOUIVVJBYDFKD-XKCDOFEDSA-N (1R,9R,10S,11R,12R,15S,18S,21R)-10,11,21-trihydroxy-8,8-dimethyl-14-methylidene-4-(prop-2-enylamino)-20-oxa-5-thia-3-azahexacyclo[9.7.2.112,15.01,9.02,6.012,18]henicosa-2(6),3-dien-13-one Chemical compound C([C@@H]1[C@@H](O)[C@@]23C(C1=C)=O)C[C@H]2[C@]12C(N=C(NCC=C)S4)=C4CC(C)(C)[C@H]1[C@H](O)[C@]3(O)OC2 UAOUIVVJBYDFKD-XKCDOFEDSA-N 0.000 claims 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 claims 2
- GLGNXYJARSMNGJ-VKTIVEEGSA-N (1s,2s,3r,4r)-3-[[5-chloro-2-[(1-ethyl-6-methoxy-2-oxo-4,5-dihydro-3h-1-benzazepin-7-yl)amino]pyrimidin-4-yl]amino]bicyclo[2.2.1]hept-5-ene-2-carboxamide Chemical compound CCN1C(=O)CCCC2=C(OC)C(NC=3N=C(C(=CN=3)Cl)N[C@H]3[C@H]([C@@]4([H])C[C@@]3(C=C4)[H])C(N)=O)=CC=C21 GLGNXYJARSMNGJ-VKTIVEEGSA-N 0.000 claims 2
- SZUVGFMDDVSKSI-WIFOCOSTSA-N (1s,2s,3s,5r)-1-(carboxymethyl)-3,5-bis[(4-phenoxyphenyl)methyl-propylcarbamoyl]cyclopentane-1,2-dicarboxylic acid Chemical compound O=C([C@@H]1[C@@H]([C@](CC(O)=O)([C@H](C(=O)N(CCC)CC=2C=CC(OC=3C=CC=CC=3)=CC=2)C1)C(O)=O)C(O)=O)N(CCC)CC(C=C1)=CC=C1OC1=CC=CC=C1 SZUVGFMDDVSKSI-WIFOCOSTSA-N 0.000 claims 2
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 claims 2
- GCTFTMWXZFLTRR-GFCCVEGCSA-N (2r)-2-amino-n-[3-(difluoromethoxy)-4-(1,3-oxazol-5-yl)phenyl]-4-methylpentanamide Chemical compound FC(F)OC1=CC(NC(=O)[C@H](N)CC(C)C)=CC=C1C1=CN=CO1 GCTFTMWXZFLTRR-GFCCVEGCSA-N 0.000 claims 2
- ITOFPJRDSCGOSA-KZLRUDJFSA-N (2s)-2-[[(4r)-4-[(3r,5r,8r,9s,10s,13r,14s,17r)-3-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H](CC[C@]13C)[C@@H]2[C@@H]3CC[C@@H]1[C@H](C)CCC(=O)N[C@H](C(O)=O)CC1=CNC2=CC=CC=C12 ITOFPJRDSCGOSA-KZLRUDJFSA-N 0.000 claims 2
- WWTBZEKOSBFBEM-SPWPXUSOSA-N (2s)-2-[[2-benzyl-3-[hydroxy-[(1r)-2-phenyl-1-(phenylmethoxycarbonylamino)ethyl]phosphoryl]propanoyl]amino]-3-(1h-indol-3-yl)propanoic acid Chemical compound N([C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)O)C(=O)C(CP(O)(=O)[C@H](CC=1C=CC=CC=1)NC(=O)OCC=1C=CC=CC=1)CC1=CC=CC=C1 WWTBZEKOSBFBEM-SPWPXUSOSA-N 0.000 claims 2
- QFLWZFQWSBQYPS-AWRAUJHKSA-N (3S)-3-[[(2S)-2-[[(2S)-2-[5-[(3aS,6aR)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]-3-methylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-4-[1-bis(4-chlorophenoxy)phosphorylbutylamino]-4-oxobutanoic acid Chemical compound CCCC(NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H](NC(=O)CCCCC1SC[C@@H]2NC(=O)N[C@H]12)C(C)C)P(=O)(Oc1ccc(Cl)cc1)Oc1ccc(Cl)cc1 QFLWZFQWSBQYPS-AWRAUJHKSA-N 0.000 claims 2
- FNHHVPPSBFQMEL-KQHDFZBMSA-N (3S)-5-N-[(1S,5R)-3-hydroxy-6-bicyclo[3.1.0]hexanyl]-7-N,3-dimethyl-3-phenyl-2H-1-benzofuran-5,7-dicarboxamide Chemical compound CNC(=O)c1cc(cc2c1OC[C@@]2(C)c1ccccc1)C(=O)NC1[C@H]2CC(O)C[C@@H]12 FNHHVPPSBFQMEL-KQHDFZBMSA-N 0.000 claims 2
- IWZSHWBGHQBIML-ZGGLMWTQSA-N (3S,8S,10R,13S,14S,17S)-17-isoquinolin-7-yl-N,N,10,13-tetramethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-amine Chemical compound CN(C)[C@H]1CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC[C@@H]4c4ccc5ccncc5c4)[C@@H]3CC=C2C1 IWZSHWBGHQBIML-ZGGLMWTQSA-N 0.000 claims 2
- OOKAZRDERJMRCJ-KOUAFAAESA-N (3r)-7-[(1s,2s,4ar,6s,8s)-2,6-dimethyl-8-[(2s)-2-methylbutanoyl]oxy-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]-3-hydroxy-5-oxoheptanoic acid Chemical compound C1=C[C@H](C)[C@H](CCC(=O)C[C@@H](O)CC(O)=O)C2[C@@H](OC(=O)[C@@H](C)CC)C[C@@H](C)C[C@@H]21 OOKAZRDERJMRCJ-KOUAFAAESA-N 0.000 claims 2
- OIIOPWHTJZYKIL-PMACEKPBSA-N (5S)-5-[[[5-[2-chloro-3-[2-chloro-3-[6-methoxy-5-[[[(2S)-5-oxopyrrolidin-2-yl]methylamino]methyl]pyrazin-2-yl]phenyl]phenyl]-3-methoxypyrazin-2-yl]methylamino]methyl]pyrrolidin-2-one Chemical compound C1(=C(N=C(C2=C(C(C3=CC=CC(=C3Cl)C3=NC(OC)=C(N=C3)CNC[C@H]3NC(=O)CC3)=CC=C2)Cl)C=N1)OC)CNC[C@H]1NC(=O)CC1 OIIOPWHTJZYKIL-PMACEKPBSA-N 0.000 claims 2
- DEVSOMFAQLZNKR-RJRFIUFISA-N (z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-n'-pyrazin-2-ylprop-2-enehydrazide Chemical compound FC(F)(F)C1=CC(C(F)(F)F)=CC(C2=NN(\C=C/C(=O)NNC=3N=CC=NC=3)C=N2)=C1 DEVSOMFAQLZNKR-RJRFIUFISA-N 0.000 claims 2
- KKHFRAFPESRGGD-UHFFFAOYSA-N 1,3-dimethyl-7-[3-(n-methylanilino)propyl]purine-2,6-dione Chemical compound C1=NC=2N(C)C(=O)N(C)C(=O)C=2N1CCCN(C)C1=CC=CC=C1 KKHFRAFPESRGGD-UHFFFAOYSA-N 0.000 claims 2
- ILROLYQPRYHHFG-UHFFFAOYSA-N 1-$l^{1}-oxidanylprop-2-en-1-one Chemical class [O]C(=O)C=C ILROLYQPRYHHFG-UHFFFAOYSA-N 0.000 claims 2
- MHSLDASSAFCCDO-UHFFFAOYSA-N 1-(5-tert-butyl-2-methylpyrazol-3-yl)-3-(4-pyridin-4-yloxyphenyl)urea Chemical compound CN1N=C(C(C)(C)C)C=C1NC(=O)NC(C=C1)=CC=C1OC1=CC=NC=C1 MHSLDASSAFCCDO-UHFFFAOYSA-N 0.000 claims 2
- KQZLRWGGWXJPOS-NLFPWZOASA-N 1-[(1R)-1-(2,4-dichlorophenyl)ethyl]-6-[(4S,5R)-4-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-5-methylcyclohexen-1-yl]pyrazolo[3,4-b]pyrazine-3-carbonitrile Chemical compound ClC1=C(C=CC(=C1)Cl)[C@@H](C)N1N=C(C=2C1=NC(=CN=2)C1=CC[C@@H]([C@@H](C1)C)N1[C@@H](CCC1)CO)C#N KQZLRWGGWXJPOS-NLFPWZOASA-N 0.000 claims 2
- WZZBNLYBHUDSHF-DHLKQENFSA-N 1-[(3s,4s)-4-[8-(2-chloro-4-pyrimidin-2-yloxyphenyl)-7-fluoro-2-methylimidazo[4,5-c]quinolin-1-yl]-3-fluoropiperidin-1-yl]-2-hydroxyethanone Chemical compound CC1=NC2=CN=C3C=C(F)C(C=4C(=CC(OC=5N=CC=CN=5)=CC=4)Cl)=CC3=C2N1[C@H]1CCN(C(=O)CO)C[C@@H]1F WZZBNLYBHUDSHF-DHLKQENFSA-N 0.000 claims 2
- ONBQEOIKXPHGMB-VBSBHUPXSA-N 1-[2-[(2s,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-4,6-dihydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1OC1=CC(O)=CC(O)=C1C(=O)CCC1=CC=C(O)C=C1 ONBQEOIKXPHGMB-VBSBHUPXSA-N 0.000 claims 2
- WGFNXGPBPIJYLI-UHFFFAOYSA-N 2,6-difluoro-3-[(3-fluorophenyl)sulfonylamino]-n-(3-methoxy-1h-pyrazolo[3,4-b]pyridin-5-yl)benzamide Chemical compound C1=C2C(OC)=NNC2=NC=C1NC(=O)C(C=1F)=C(F)C=CC=1NS(=O)(=O)C1=CC=CC(F)=C1 WGFNXGPBPIJYLI-UHFFFAOYSA-N 0.000 claims 2
- VCUXVXLUOHDHKK-UHFFFAOYSA-N 2-(2-aminopyrimidin-4-yl)-4-(2-chloro-4-methoxyphenyl)-1,3-thiazole-5-carboxamide Chemical compound ClC1=CC(OC)=CC=C1C1=C(C(N)=O)SC(C=2N=C(N)N=CC=2)=N1 VCUXVXLUOHDHKK-UHFFFAOYSA-N 0.000 claims 2
- MDFXJBQEWLCGHP-MFOYZWKCSA-N 2-[2-[(z)-(pyridine-4-carbonylhydrazinylidene)methyl]phenoxy]acetic acid Chemical compound OC(=O)COC1=CC=CC=C1\C=N/NC(=O)C1=CC=NC=C1 MDFXJBQEWLCGHP-MFOYZWKCSA-N 0.000 claims 2
- FMKGJQHNYMWDFJ-CVEARBPZSA-N 2-[[4-(2,2-difluoropropoxy)pyrimidin-5-yl]methylamino]-4-[[(1R,4S)-4-hydroxy-3,3-dimethylcyclohexyl]amino]pyrimidine-5-carbonitrile Chemical compound FC(COC1=NC=NC=C1CNC1=NC=C(C(=N1)N[C@H]1CC([C@H](CC1)O)(C)C)C#N)(C)F FMKGJQHNYMWDFJ-CVEARBPZSA-N 0.000 claims 2
- PAYROHWFGZADBR-UHFFFAOYSA-N 2-[[4-amino-5-(5-iodo-4-methoxy-2-propan-2-ylphenoxy)pyrimidin-2-yl]amino]propane-1,3-diol Chemical compound C1=C(I)C(OC)=CC(C(C)C)=C1OC1=CN=C(NC(CO)CO)N=C1N PAYROHWFGZADBR-UHFFFAOYSA-N 0.000 claims 2
- VVCMGAUPZIKYTH-VGHSCWAPSA-N 2-acetyloxybenzoic acid;[(2s,3r)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;1,3,7-trimethylpurine-2,6-dione Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O.CN1C(=O)N(C)C(=O)C2=C1N=CN2C.C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 VVCMGAUPZIKYTH-VGHSCWAPSA-N 0.000 claims 2
- YSUIQYOGTINQIN-UZFYAQMZSA-N 2-amino-9-[(1S,6R,8R,9S,10R,15R,17R,18R)-8-(6-aminopurin-9-yl)-9,18-difluoro-3,12-dihydroxy-3,12-bis(sulfanylidene)-2,4,7,11,13,16-hexaoxa-3lambda5,12lambda5-diphosphatricyclo[13.2.1.06,10]octadecan-17-yl]-1H-purin-6-one Chemical compound NC1=NC2=C(N=CN2[C@@H]2O[C@@H]3COP(S)(=O)O[C@@H]4[C@@H](COP(S)(=O)O[C@@H]2[C@@H]3F)O[C@H]([C@H]4F)N2C=NC3=C2N=CN=C3N)C(=O)N1 YSUIQYOGTINQIN-UZFYAQMZSA-N 0.000 claims 2
- TVTJUIAKQFIXCE-HUKYDQBMSA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynyl-1H-purine-6,8-dione Chemical compound NC=1NC(C=2N(C(N(C=2N=1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C)=O TVTJUIAKQFIXCE-HUKYDQBMSA-N 0.000 claims 2
- NPRYCHLHHVWLQZ-TURQNECASA-N 2-amino-9-[(2R,3S,4S,5R)-4-fluoro-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7-prop-2-ynylpurin-8-one Chemical compound NC1=NC=C2N(C(N(C2=N1)[C@@H]1O[C@@H]([C@H]([C@H]1O)F)CO)=O)CC#C NPRYCHLHHVWLQZ-TURQNECASA-N 0.000 claims 2
- LFOIDLOIBZFWDO-UHFFFAOYSA-N 2-methoxy-6-[6-methoxy-4-[(3-phenylmethoxyphenyl)methoxy]-1-benzofuran-2-yl]imidazo[2,1-b][1,3,4]thiadiazole Chemical compound N1=C2SC(OC)=NN2C=C1C(OC1=CC(OC)=C2)=CC1=C2OCC(C=1)=CC=CC=1OCC1=CC=CC=C1 LFOIDLOIBZFWDO-UHFFFAOYSA-N 0.000 claims 2
- VFTQRHWULYJKCI-UHFFFAOYSA-N 3-(1-adamantyl)-6,7,8,9-tetrahydro-5h-[1,2,4]triazolo[4,3-a]azepine Chemical compound C1CCCCN2C(C34CC5CC(C4)CC(C3)C5)=NN=C21 VFTQRHWULYJKCI-UHFFFAOYSA-N 0.000 claims 2
- QBWKPGNFQQJGFY-QLFBSQMISA-N 3-[(1r)-1-[(2r,6s)-2,6-dimethylmorpholin-4-yl]ethyl]-n-[6-methyl-3-(1h-pyrazol-4-yl)imidazo[1,2-a]pyrazin-8-yl]-1,2-thiazol-5-amine Chemical compound N1([C@H](C)C2=NSC(NC=3C4=NC=C(N4C=C(C)N=3)C3=CNN=C3)=C2)C[C@H](C)O[C@H](C)C1 QBWKPGNFQQJGFY-QLFBSQMISA-N 0.000 claims 2
- WXYZLSHVMIALBJ-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-methylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CN(C)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl WXYZLSHVMIALBJ-UHFFFAOYSA-N 0.000 claims 2
- JOAHXELYGZYEKF-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(1-piperidin-4-ylethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(C)C1CCNCC1 JOAHXELYGZYEKF-UHFFFAOYSA-N 0.000 claims 2
- QZRSIMHJKPJNGI-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(3-methylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1CNCCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl QZRSIMHJKPJNGI-UHFFFAOYSA-N 0.000 claims 2
- CQLXPMMPXLISJD-UHFFFAOYSA-N 3-[(2-bromophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1Br CQLXPMMPXLISJD-UHFFFAOYSA-N 0.000 claims 2
- QPTYHBIZVDVMIN-UHFFFAOYSA-N 3-[(2-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCCCC1C QPTYHBIZVDVMIN-UHFFFAOYSA-N 0.000 claims 2
- BACMTCNFHNDMIM-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 BACMTCNFHNDMIM-UHFFFAOYSA-N 0.000 claims 2
- YXRRWLMKILIUQE-UHFFFAOYSA-N 3-[(4-methylbenzoyl)-[[3-(trifluoromethyl)phenyl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)CC1=CC=CC(C(F)(F)F)=C1 YXRRWLMKILIUQE-UHFFFAOYSA-N 0.000 claims 2
- OFDSKMIBUWTRLA-UHFFFAOYSA-N 3-[(4-tert-butylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C(C)(C)C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 OFDSKMIBUWTRLA-UHFFFAOYSA-N 0.000 claims 2
- TZZDVPMABRWKIZ-MFTLXVFQSA-N 3-[6-[4-[[1-[4-[(1R,2S)-6-hydroxy-2-phenyl-1,2,3,4-tetrahydronaphthalen-1-yl]phenyl]piperidin-4-yl]methyl]piperazin-1-yl]-3-oxo-1H-isoindol-2-yl]piperidine-2,6-dione Chemical compound OC=1C=C2CC[C@@H]([C@@H](C2=CC=1)C1=CC=C(C=C1)N1CCC(CC1)CN1CCN(CC1)C=1C=C2CN(C(C2=CC=1)=O)C1C(NC(CC1)=O)=O)C1=CC=CC=C1 TZZDVPMABRWKIZ-MFTLXVFQSA-N 0.000 claims 2
- DVUBOJMLFXVTBH-UHFFFAOYSA-N 3-[[5-(3-chloro-4-fluorophenyl)thiophen-2-yl]methyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)CC(S1)=CC=C1C1=CC=C(F)C(Cl)=C1 DVUBOJMLFXVTBH-UHFFFAOYSA-N 0.000 claims 2
- HNXVUHHNOWQZLR-UHFFFAOYSA-N 3-[acetyl(benzyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C)CC1=CC=CC=C1 HNXVUHHNOWQZLR-UHFFFAOYSA-N 0.000 claims 2
- OMMRCJMTUFZTIB-UHFFFAOYSA-N 3-[but-2-enoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C(=O)C=CC)CC)C=C1C1=CC=CC=C1 OMMRCJMTUFZTIB-UHFFFAOYSA-N 0.000 claims 2
- IZHUPPBRYPCMKI-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=CSC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 IZHUPPBRYPCMKI-UHFFFAOYSA-N 0.000 claims 2
- XWQVQSXLXAXOPJ-QNGMFEMESA-N 4-[[[6-[5-chloro-2-[[4-[[(2r)-1-methoxypropan-2-yl]amino]cyclohexyl]amino]pyridin-4-yl]pyridin-2-yl]amino]methyl]oxane-4-carbonitrile Chemical compound C1CC(N[C@H](C)COC)CCC1NC1=CC(C=2N=C(NCC3(CCOCC3)C#N)C=CC=2)=C(Cl)C=N1 XWQVQSXLXAXOPJ-QNGMFEMESA-N 0.000 claims 2
- LVOZLWLORQRMMV-UHFFFAOYSA-N 5-(2,4-dichlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C(=CC(Cl)=CC=2)Cl)=C1 LVOZLWLORQRMMV-UHFFFAOYSA-N 0.000 claims 2
- NFXZBSGFEIDKTI-UHFFFAOYSA-N 5-(3,4-difluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(F)C(F)=CC=2)=C1 NFXZBSGFEIDKTI-UHFFFAOYSA-N 0.000 claims 2
- XFJBGINZIMNZBW-CRAIPNDOSA-N 5-chloro-2-[4-[(1r,2s)-2-[2-(5-methylsulfonylpyridin-2-yl)oxyethyl]cyclopropyl]piperidin-1-yl]pyrimidine Chemical compound N1=CC(S(=O)(=O)C)=CC=C1OCC[C@H]1[C@@H](C2CCN(CC2)C=2N=CC(Cl)=CN=2)C1 XFJBGINZIMNZBW-CRAIPNDOSA-N 0.000 claims 2
- YZSCPLGKKMSBMV-UHFFFAOYSA-N 5-fluoro-4-(8-fluoro-4-propan-2-yl-2,3-dihydro-1,4-benzoxazin-6-yl)-N-[5-(1-methylpiperidin-4-yl)pyridin-2-yl]pyrimidin-2-amine Chemical compound FC=1C(=NC(=NC=1)NC1=NC=C(C=C1)C1CCN(CC1)C)C1=CC2=C(OCCN2C(C)C)C(=C1)F YZSCPLGKKMSBMV-UHFFFAOYSA-N 0.000 claims 2
- LVUCWLUPSLTAQY-UHFFFAOYSA-N 5-tert-butyl-3-[(4-chlorophenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound S1C(C(C)(C)C)=CC(NS(=O)(=O)C=2C=CC(Cl)=CC=2)=C1C(O)=O LVUCWLUPSLTAQY-UHFFFAOYSA-N 0.000 claims 2
- RSIWALKZYXPAGW-NSHDSACASA-N 6-(3-fluorophenyl)-3-methyl-7-[(1s)-1-(7h-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one Chemical compound C=1([C@@H](NC=2C=3N=CNC=3N=CN=2)C)N=C2SC=C(C)N2C(=O)C=1C1=CC=CC(F)=C1 RSIWALKZYXPAGW-NSHDSACASA-N 0.000 claims 2
- NJIAKNWTIVDSDA-FQEVSTJZSA-N 7-[4-(1-methylsulfonylpiperidin-4-yl)phenyl]-n-[[(2s)-morpholin-2-yl]methyl]pyrido[3,4-b]pyrazin-5-amine Chemical compound C1CN(S(=O)(=O)C)CCC1C1=CC=C(C=2N=C(NC[C@H]3OCCNC3)C3=NC=CN=C3C=2)C=C1 NJIAKNWTIVDSDA-FQEVSTJZSA-N 0.000 claims 2
- IRBAWVGZNJIROV-SFHVURJKSA-N 9-(2-cyclopropylethynyl)-2-[[(2s)-1,4-dioxan-2-yl]methoxy]-6,7-dihydropyrimido[6,1-a]isoquinolin-4-one Chemical compound C1=C2C3=CC=C(C#CC4CC4)C=C3CCN2C(=O)N=C1OC[C@@H]1COCCO1 IRBAWVGZNJIROV-SFHVURJKSA-N 0.000 claims 2
- JQUCWIWWWKZNCS-LESHARBVSA-N C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F Chemical compound C(C1=CC=CC=C1)(=O)NC=1SC[C@H]2[C@@](N1)(CO[C@H](C2)C)C=2SC=C(N2)NC(=O)C2=NC=C(C=C2)OC(F)F JQUCWIWWWKZNCS-LESHARBVSA-N 0.000 claims 2
- SYZOFRXZMALRGI-JYJNAYRXSA-N CC1=C(NCC(F)(F)F)C(=O)N(C=C1)[C@@H](CC1CC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C#N Chemical compound CC1=C(NCC(F)(F)F)C(=O)N(C=C1)[C@@H](CC1CC1)C(=O)N[C@@H](C[C@@H]1CCNC1=O)C#N SYZOFRXZMALRGI-JYJNAYRXSA-N 0.000 claims 2
- UHNRLQRZRNKOKU-UHFFFAOYSA-N CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O Chemical compound CCN(CC1=NC2=C(N1)C1=CC=C(C=C1N=C2N)C1=NNC=C1)C(C)=O UHNRLQRZRNKOKU-UHFFFAOYSA-N 0.000 claims 2
- SCJNYBYSTCRPAO-LXBQGUBHSA-N CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 Chemical compound CN(C)C\C=C\C(=O)NC1=CC=C(N=C1)C(=O)N[C@@]1(C)CCC[C@H](C1)NC1=NC(C2=CNC3=CC=CC=C23)=C(Cl)C=N1 SCJNYBYSTCRPAO-LXBQGUBHSA-N 0.000 claims 2
- 229940126657 Compound 17 Drugs 0.000 claims 2
- 229940126639 Compound 33 Drugs 0.000 claims 2
- 229940127007 Compound 39 Drugs 0.000 claims 2
- RRSNDVCODIMOFX-MPKOGUQCSA-N Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O Chemical compound Fc1c(Cl)cccc1[C@H]1[C@@H](NC2(CCCCC2)[C@@]11C(=O)Nc2cc(Cl)ccc12)C(=O)Nc1ccc(cc1)C(=O)NCCCCCc1cccc2C(=O)N(Cc12)C1CCC(=O)NC1=O RRSNDVCODIMOFX-MPKOGUQCSA-N 0.000 claims 2
- LVDRREOUMKACNJ-BKMJKUGQSA-N N-[(2R,3S)-2-(4-chlorophenyl)-1-(1,4-dimethyl-2-oxoquinolin-7-yl)-6-oxopiperidin-3-yl]-2-methylpropane-1-sulfonamide Chemical compound CC(C)CS(=O)(=O)N[C@H]1CCC(=O)N([C@@H]1c1ccc(Cl)cc1)c1ccc2c(C)cc(=O)n(C)c2c1 LVDRREOUMKACNJ-BKMJKUGQSA-N 0.000 claims 2
- OPFJDXRVMFKJJO-ZHHKINOHSA-N N-{[3-(2-benzamido-4-methyl-1,3-thiazol-5-yl)-pyrazol-5-yl]carbonyl}-G-dR-G-dD-dD-dD-NH2 Chemical compound S1C(C=2NN=C(C=2)C(=O)NCC(=O)N[C@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC(O)=O)C(N)=O)=C(C)N=C1NC(=O)C1=CC=CC=C1 OPFJDXRVMFKJJO-ZHHKINOHSA-N 0.000 claims 2
- QOVYHDHLFPKQQG-NDEPHWFRSA-N N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O Chemical compound N[C@@H](CCC(=O)N1CCC(CC1)NC1=C2C=CC=CC2=NC(NCC2=CN(CCCNCCCNC3CCCCC3)N=N2)=N1)C(O)=O QOVYHDHLFPKQQG-NDEPHWFRSA-N 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- PNUZDKCDAWUEGK-CYZMBNFOSA-N Sitafloxacin Chemical compound C([C@H]1N)N(C=2C(=C3C(C(C(C(O)=O)=CN3[C@H]3[C@H](C3)F)=O)=CC=2F)Cl)CC11CC1 PNUZDKCDAWUEGK-CYZMBNFOSA-N 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- LJOOWESTVASNOG-UFJKPHDISA-N [(1s,3r,4ar,7s,8s,8as)-3-hydroxy-8-[2-[(4r)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-1-yl] (2s)-2-methylbutanoate Chemical compound C([C@H]1[C@@H](C)C=C[C@H]2C[C@@H](O)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)CC1C[C@@H](O)CC(=O)O1 LJOOWESTVASNOG-UFJKPHDISA-N 0.000 claims 2
- LNUFLCYMSVYYNW-ZPJMAFJPSA-N [(2r,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[(2r,3r,4s,5r,6r)-6-[[(3s,5s,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-disulfo Chemical compound O([C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1[C@@H](COS(O)(=O)=O)O[C@H]([C@@H]([C@H]1OS(O)(=O)=O)OS(O)(=O)=O)O[C@@H]1C[C@@H]2CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CCCC(C)C)[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](OS(O)(=O)=O)[C@H](OS(O)(=O)=O)[C@H]1OS(O)(=O)=O LNUFLCYMSVYYNW-ZPJMAFJPSA-N 0.000 claims 2
- SMNRFWMNPDABKZ-WVALLCKVSA-N [[(2R,3S,4R,5S)-5-(2,6-dioxo-3H-pyridin-3-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4S,5R,6R)-4-fluoro-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(=O)OP(O)(=O)OP(O)(=O)OP(O)(=O)OC[C@H]2O[C@H]([C@H](O)[C@@H]2O)C2C=CC(=O)NC2=O)[C@H](O)[C@@H](F)[C@@H]1O SMNRFWMNPDABKZ-WVALLCKVSA-N 0.000 claims 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 2
- QBYJBZPUGVGKQQ-SJJAEHHWSA-N aldrin Chemical compound C1[C@H]2C=C[C@@H]1[C@H]1[C@@](C3(Cl)Cl)(Cl)C(Cl)=C(Cl)[C@@]3(Cl)[C@H]12 QBYJBZPUGVGKQQ-SJJAEHHWSA-N 0.000 claims 2
- XRWSZZJLZRKHHD-WVWIJVSJSA-N asunaprevir Chemical compound O=C([C@@H]1C[C@H](CN1C(=O)[C@@H](NC(=O)OC(C)(C)C)C(C)(C)C)OC1=NC=C(C2=CC=C(Cl)C=C21)OC)N[C@]1(C(=O)NS(=O)(=O)C2CC2)C[C@H]1C=C XRWSZZJLZRKHHD-WVWIJVSJSA-N 0.000 claims 2
- OTKPPUXRIADSGD-PPRNARJGSA-N avoparcina Chemical compound O([C@@H]1C2=CC=C(C(=C2)Cl)OC=2C=C3C=C(C=2O[C@H]2C([C@@H](O)[C@H](O)[C@@H](CO)O2)O[C@@H]2O[C@@H](C)[C@H](O)[C@H](N)C2)OC2=CC=C(C=C2)[C@@H](O)[C@H](C(N[C@H](C(=O)N[C@H]3C(=O)N[C@H]2C(=O)N[C@@H]1C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)C=1C=CC(O)=CC=1)=O)NC(=O)[C@H](NC)C=1C=CC(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)=CC=1)[C@H]1C[C@@H](N)[C@@H](O)[C@H](C)O1 OTKPPUXRIADSGD-PPRNARJGSA-N 0.000 claims 2
- 229940125904 compound 1 Drugs 0.000 claims 2
- 229940125773 compound 10 Drugs 0.000 claims 2
- 229940125797 compound 12 Drugs 0.000 claims 2
- 229940126543 compound 14 Drugs 0.000 claims 2
- 229940125758 compound 15 Drugs 0.000 claims 2
- 229940126142 compound 16 Drugs 0.000 claims 2
- 229940125782 compound 2 Drugs 0.000 claims 2
- 229940125810 compound 20 Drugs 0.000 claims 2
- 229940126086 compound 21 Drugs 0.000 claims 2
- 229940126208 compound 22 Drugs 0.000 claims 2
- 229940125833 compound 23 Drugs 0.000 claims 2
- 229940125961 compound 24 Drugs 0.000 claims 2
- 229940125846 compound 25 Drugs 0.000 claims 2
- 229940125851 compound 27 Drugs 0.000 claims 2
- 229940127204 compound 29 Drugs 0.000 claims 2
- 229940126214 compound 3 Drugs 0.000 claims 2
- 229940125877 compound 31 Drugs 0.000 claims 2
- 229940125878 compound 36 Drugs 0.000 claims 2
- 229940125807 compound 37 Drugs 0.000 claims 2
- 229940127573 compound 38 Drugs 0.000 claims 2
- 229940126540 compound 41 Drugs 0.000 claims 2
- 229940125936 compound 42 Drugs 0.000 claims 2
- 229940125844 compound 46 Drugs 0.000 claims 2
- 229940127271 compound 49 Drugs 0.000 claims 2
- 229940125898 compound 5 Drugs 0.000 claims 2
- 229940126545 compound 53 Drugs 0.000 claims 2
- 229940127113 compound 57 Drugs 0.000 claims 2
- 229940125900 compound 59 Drugs 0.000 claims 2
- 229940126179 compound 72 Drugs 0.000 claims 2
- UKJLNMAFNRKWGR-UHFFFAOYSA-N cyclohexatrienamine Chemical class NC1=CC=C=C[CH]1 UKJLNMAFNRKWGR-UHFFFAOYSA-N 0.000 claims 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims 2
- BFXLJWUGRPGMFU-UHFFFAOYSA-N dipropoxyphosphinothioyl n,n-diethylcarbamodithioate;sulfane Chemical compound S.CCCOP(=S)(OCCC)SC(=S)N(CC)CC BFXLJWUGRPGMFU-UHFFFAOYSA-N 0.000 claims 2
- JPGQOUSTVILISH-UHFFFAOYSA-N enflurane Chemical compound FC(F)OC(F)(F)C(F)Cl JPGQOUSTVILISH-UHFFFAOYSA-N 0.000 claims 2
- GWNFQAKCJYEJEW-UHFFFAOYSA-N ethyl 3-[8-[[4-methyl-5-[(3-methyl-4-oxophthalazin-1-yl)methyl]-1,2,4-triazol-3-yl]sulfanyl]octanoylamino]benzoate Chemical compound CCOC(=O)C1=CC(NC(=O)CCCCCCCSC2=NN=C(CC3=NN(C)C(=O)C4=CC=CC=C34)N2C)=CC=C1 GWNFQAKCJYEJEW-UHFFFAOYSA-N 0.000 claims 2
- 230000005764 inhibitory process Effects 0.000 claims 2
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 claims 2
- ZBELDPMWYXDLNY-UHFFFAOYSA-N methyl 9-(4-bromo-2-fluoroanilino)-[1,3]thiazolo[5,4-f]quinazoline-2-carboximidate Chemical compound C12=C3SC(C(=N)OC)=NC3=CC=C2N=CN=C1NC1=CC=C(Br)C=C1F ZBELDPMWYXDLNY-UHFFFAOYSA-N 0.000 claims 2
- YCJZWBZJSYLMPB-UHFFFAOYSA-N n-(2-chloropyrimidin-4-yl)-2,5-dimethyl-1-phenylimidazole-4-carboxamide Chemical compound CC=1N(C=2C=CC=CC=2)C(C)=NC=1C(=O)NC1=CC=NC(Cl)=N1 YCJZWBZJSYLMPB-UHFFFAOYSA-N 0.000 claims 2
- IHCHOVVAJBADAH-UHFFFAOYSA-N n-[2-hydroxy-4-(1h-pyrazol-4-yl)phenyl]-6-methoxy-3,4-dihydro-2h-chromene-3-carboxamide Chemical compound C1C2=CC(OC)=CC=C2OCC1C(=O)NC(C(=C1)O)=CC=C1C=1C=NNC=1 IHCHOVVAJBADAH-UHFFFAOYSA-N 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 125000003386 piperidinyl group Chemical group 0.000 claims 2
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims 2
- 125000000168 pyrrolyl group Chemical group 0.000 claims 2
- KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 claims 2
- ASGMFNBUXDJWJJ-JLCFBVMHSA-N (1R,3R)-3-[[3-bromo-1-[4-(5-methyl-1,3,4-thiadiazol-2-yl)phenyl]pyrazolo[3,4-d]pyrimidin-6-yl]amino]-N,1-dimethylcyclopentane-1-carboxamide Chemical compound BrC1=NN(C2=NC(=NC=C21)N[C@H]1C[C@@](CC1)(C(=O)NC)C)C1=CC=C(C=C1)C=1SC(=NN=1)C ASGMFNBUXDJWJJ-JLCFBVMHSA-N 0.000 claims 1
- ABJSOROVZZKJGI-OCYUSGCXSA-N (1r,2r,4r)-2-(4-bromophenyl)-n-[(4-chlorophenyl)-(2-fluoropyridin-4-yl)methyl]-4-morpholin-4-ylcyclohexane-1-carboxamide Chemical compound C1=NC(F)=CC(C(NC(=O)[C@H]2[C@@H](C[C@@H](CC2)N2CCOCC2)C=2C=CC(Br)=CC=2)C=2C=CC(Cl)=CC=2)=C1 ABJSOROVZZKJGI-OCYUSGCXSA-N 0.000 claims 1
- IUSARDYWEPUTPN-OZBXUNDUSA-N (2r)-n-[(2s,3r)-4-[[(4s)-6-(2,2-dimethylpropyl)spiro[3,4-dihydropyrano[2,3-b]pyridine-2,1'-cyclobutane]-4-yl]amino]-3-hydroxy-1-[3-(1,3-thiazol-2-yl)phenyl]butan-2-yl]-2-methoxypropanamide Chemical compound C([C@H](NC(=O)[C@@H](C)OC)[C@H](O)CN[C@@H]1C2=CC(CC(C)(C)C)=CN=C2OC2(CCC2)C1)C(C=1)=CC=CC=1C1=NC=CS1 IUSARDYWEPUTPN-OZBXUNDUSA-N 0.000 claims 1
- YJLIKUSWRSEPSM-WGQQHEPDSA-N (2r,3r,4s,5r)-2-[6-amino-8-[(4-phenylphenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1CNC1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O YJLIKUSWRSEPSM-WGQQHEPDSA-N 0.000 claims 1
- VIJSPAIQWVPKQZ-BLECARSGSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-5-(diaminomethylideneamino)pentanoyl]amino]-4-methylpentanoyl]amino]-4,4-dimethylpentanoyl]amino]-4-methylpentanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(C)=O VIJSPAIQWVPKQZ-BLECARSGSA-N 0.000 claims 1
- UDQTXCHQKHIQMH-KYGLGHNPSA-N (3ar,5s,6s,7r,7ar)-5-(difluoromethyl)-2-(ethylamino)-5,6,7,7a-tetrahydro-3ah-pyrano[3,2-d][1,3]thiazole-6,7-diol Chemical compound S1C(NCC)=N[C@H]2[C@@H]1O[C@H](C(F)F)[C@@H](O)[C@@H]2O UDQTXCHQKHIQMH-KYGLGHNPSA-N 0.000 claims 1
- HUWSZNZAROKDRZ-RRLWZMAJSA-N (3r,4r)-3-azaniumyl-5-[[(2s,3r)-1-[(2s)-2,3-dicarboxypyrrolidin-1-yl]-3-methyl-1-oxopentan-2-yl]amino]-5-oxo-4-sulfanylpentane-1-sulfonate Chemical compound OS(=O)(=O)CC[C@@H](N)[C@@H](S)C(=O)N[C@@H]([C@H](C)CC)C(=O)N1CCC(C(O)=O)[C@H]1C(O)=O HUWSZNZAROKDRZ-RRLWZMAJSA-N 0.000 claims 1
- MPDDTAJMJCESGV-CTUHWIOQSA-M (3r,5r)-7-[2-(4-fluorophenyl)-5-[methyl-[(1r)-1-phenylethyl]carbamoyl]-4-propan-2-ylpyrazol-3-yl]-3,5-dihydroxyheptanoate Chemical compound C1([C@@H](C)N(C)C(=O)C2=NN(C(CC[C@@H](O)C[C@@H](O)CC([O-])=O)=C2C(C)C)C=2C=CC(F)=CC=2)=CC=CC=C1 MPDDTAJMJCESGV-CTUHWIOQSA-M 0.000 claims 1
- YQOLEILXOBUDMU-KRWDZBQOSA-N (4R)-5-[(6-bromo-3-methyl-2-pyrrolidin-1-ylquinoline-4-carbonyl)amino]-4-(2-chlorophenyl)pentanoic acid Chemical compound CC1=C(C2=C(C=CC(=C2)Br)N=C1N3CCCC3)C(=O)NC[C@H](CCC(=O)O)C4=CC=CC=C4Cl YQOLEILXOBUDMU-KRWDZBQOSA-N 0.000 claims 1
- STPKWKPURVSAJF-LJEWAXOPSA-N (4r,5r)-5-[4-[[4-(1-aza-4-azoniabicyclo[2.2.2]octan-4-ylmethyl)phenyl]methoxy]phenyl]-3,3-dibutyl-7-(dimethylamino)-1,1-dioxo-4,5-dihydro-2h-1$l^{6}-benzothiepin-4-ol Chemical compound O[C@H]1C(CCCC)(CCCC)CS(=O)(=O)C2=CC=C(N(C)C)C=C2[C@H]1C(C=C1)=CC=C1OCC(C=C1)=CC=C1C[N+]1(CC2)CCN2CC1 STPKWKPURVSAJF-LJEWAXOPSA-N 0.000 claims 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 1
- GMLCQPJLSFPJMX-UHFFFAOYSA-N 1-phenylpyrrole-2-carboxylic acid Chemical compound OC(=O)C1=CC=CN1C1=CC=CC=C1 GMLCQPJLSFPJMX-UHFFFAOYSA-N 0.000 claims 1
- YBYIRNPNPLQARY-UHFFFAOYSA-N 1H-indene Natural products C1=CC=C2CC=CC2=C1 YBYIRNPNPLQARY-UHFFFAOYSA-N 0.000 claims 1
- WUEPMEXUMQVEGN-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;2,2,2-trifluoro-n-[2-[2-[(2,2,2-trifluoroacetyl)amino]ethylamino]ethyl]acetamide Chemical compound OC(=O)C(F)(F)F.FC(F)(F)C(=O)NCCNCCNC(=O)C(F)(F)F WUEPMEXUMQVEGN-UHFFFAOYSA-N 0.000 claims 1
- FILKGCRCWDMBKA-UHFFFAOYSA-N 2,6-dichloropyridine Chemical compound ClC1=CC=CC(Cl)=N1 FILKGCRCWDMBKA-UHFFFAOYSA-N 0.000 claims 1
- FQMZXMVHHKXGTM-UHFFFAOYSA-N 2-(1-adamantyl)-n-[2-[2-(2-hydroxyethylamino)ethylamino]quinolin-5-yl]acetamide Chemical compound C1C(C2)CC(C3)CC2CC13CC(=O)NC1=CC=CC2=NC(NCCNCCO)=CC=C21 FQMZXMVHHKXGTM-UHFFFAOYSA-N 0.000 claims 1
- QEBYEVQKHRUYPE-UHFFFAOYSA-N 2-(2-chlorophenyl)-5-[(1-methylpyrazol-3-yl)methyl]-4-[[methyl(pyridin-3-ylmethyl)amino]methyl]-1h-pyrazolo[4,3-c]pyridine-3,6-dione Chemical compound C1=CN(C)N=C1CN1C(=O)C=C2NN(C=3C(=CC=CC=3)Cl)C(=O)C2=C1CN(C)CC1=CC=CN=C1 QEBYEVQKHRUYPE-UHFFFAOYSA-N 0.000 claims 1
- QTMAZYGAVHCKKX-UHFFFAOYSA-N 2-[(4-amino-5-bromopyrrolo[2,3-d]pyrimidin-7-yl)methoxy]propane-1,3-diol Chemical compound NC1=NC=NC2=C1C(Br)=CN2COC(CO)CO QTMAZYGAVHCKKX-UHFFFAOYSA-N 0.000 claims 1
- PYRKKGOKRMZEIT-UHFFFAOYSA-N 2-[6-(2-cyclopropylethoxy)-9-(2-hydroxy-2-methylpropyl)-1h-phenanthro[9,10-d]imidazol-2-yl]-5-fluorobenzene-1,3-dicarbonitrile Chemical compound C1=C2C3=CC(CC(C)(O)C)=CC=C3C=3NC(C=4C(=CC(F)=CC=4C#N)C#N)=NC=3C2=CC=C1OCCC1CC1 PYRKKGOKRMZEIT-UHFFFAOYSA-N 0.000 claims 1
- HPDPVPUXPBZBOJ-UHFFFAOYSA-N 2-[chloro(difluoro)methoxy]-1,1,1-trifluoroethane Chemical compound FC(F)(F)COC(F)(F)Cl HPDPVPUXPBZBOJ-UHFFFAOYSA-N 0.000 claims 1
- BVRDQVRQVGRNHG-UHFFFAOYSA-N 2-morpholin-4-ylpyrimido[2,1-a]isoquinolin-4-one Chemical compound N1=C2C3=CC=CC=C3C=CN2C(=O)C=C1N1CCOCC1 BVRDQVRQVGRNHG-UHFFFAOYSA-N 0.000 claims 1
- DFRAKBCRUYUFNT-UHFFFAOYSA-N 3,8-dicyclohexyl-2,4,7,9-tetrahydro-[1,3]oxazino[5,6-h][1,3]benzoxazine Chemical compound C1CCCCC1N1CC(C=CC2=C3OCN(C2)C2CCCCC2)=C3OC1 DFRAKBCRUYUFNT-UHFFFAOYSA-N 0.000 claims 1
- NSTBKJQXCZFJQD-UHFFFAOYSA-N 3-(benzenesulfonamido)-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1 NSTBKJQXCZFJQD-UHFFFAOYSA-N 0.000 claims 1
- SKMKJBYBPYBDMN-RYUDHWBXSA-N 3-(difluoromethoxy)-5-[2-(3,3-difluoropyrrolidin-1-yl)-6-[(1s,4s)-2-oxa-5-azabicyclo[2.2.1]heptan-5-yl]pyrimidin-4-yl]pyridin-2-amine Chemical compound C1=C(OC(F)F)C(N)=NC=C1C1=CC(N2[C@H]3C[C@H](OC3)C2)=NC(N2CC(F)(F)CC2)=N1 SKMKJBYBPYBDMN-RYUDHWBXSA-N 0.000 claims 1
- NYYKDALOYDQKPA-UHFFFAOYSA-N 3-(n-(2,4-dichlorobenzoyl)anilino)-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C=1C=CC=CC=1)C(=O)C1=CC=C(Cl)C=C1Cl NYYKDALOYDQKPA-UHFFFAOYSA-N 0.000 claims 1
- MBGLVYUZXJBDHJ-UHFFFAOYSA-N 3-[(1-acetylpiperidin-4-yl)-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CN(C(=O)C)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl MBGLVYUZXJBDHJ-UHFFFAOYSA-N 0.000 claims 1
- HGZLUPOHPDDIFN-UHFFFAOYSA-N 3-[(2,4-dichlorobenzenecarbothioyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=S)C1=CC=C(Cl)C=C1Cl HGZLUPOHPDDIFN-UHFFFAOYSA-N 0.000 claims 1
- LJMOEDINVVMTSY-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(2-methylpropyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC(C)C)C(=O)C1=CC=C(Cl)C=C1Cl LJMOEDINVVMTSY-UHFFFAOYSA-N 0.000 claims 1
- PRJDUWACXUZMSN-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-(3-methyl-1-phenylmethoxycarbonylpiperidin-4-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1CN(C(=O)OCC=2C=CC=CC=2)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl PRJDUWACXUZMSN-UHFFFAOYSA-N 0.000 claims 1
- OQOYFCILKXRELY-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-[1-[(2-methylpropan-2-yl)oxycarbonylamino]propan-2-yl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(CNC(=O)OC(C)(C)C)C)C(=O)C1=CC=C(Cl)C=C1Cl OQOYFCILKXRELY-UHFFFAOYSA-N 0.000 claims 1
- GKOAPPFBYCPZJX-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-[[5-[3-(trifluoromethyl)phenyl]furan-2-yl]methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)CC(O1)=CC=C1C1=CC=CC(C(F)(F)F)=C1 GKOAPPFBYCPZJX-UHFFFAOYSA-N 0.000 claims 1
- ZDEYYXQNNKHDQW-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCNCC1 ZDEYYXQNNKHDQW-UHFFFAOYSA-N 0.000 claims 1
- KXCBVTIGHBAEDE-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-(4-methylsulfinylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)S(C)=O)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl KXCBVTIGHBAEDE-UHFFFAOYSA-N 0.000 claims 1
- CLVGSVVEEHMLBX-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]-5-methylthiophene-2-carboxylic acid Chemical compound C1=C(C)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl CLVGSVVEEHMLBX-UHFFFAOYSA-N 0.000 claims 1
- BVAOOKPQBDTCBU-UHFFFAOYSA-N 3-[(2,4-dichlorobenzoyl)-pyrrolidin-3-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CCNC1 BVAOOKPQBDTCBU-UHFFFAOYSA-N 0.000 claims 1
- WHIBBUNFHUZCSG-UHFFFAOYSA-N 3-[(2,4-dichlorophenyl)methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC1=CC=C(Cl)C=C1Cl WHIBBUNFHUZCSG-UHFFFAOYSA-N 0.000 claims 1
- HGTGZFRYWKDEMH-UHFFFAOYSA-N 3-[(2,4-dichlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(Cl)C=C1Cl HGTGZFRYWKDEMH-UHFFFAOYSA-N 0.000 claims 1
- QSVDOKJEQZCAAN-UHFFFAOYSA-N 3-[(2,4-dimethylphenyl)sulfonylamino]-4-methyl-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=C(C)C=1NS(=O)(=O)C1=CC=C(C)C=C1C QSVDOKJEQZCAAN-UHFFFAOYSA-N 0.000 claims 1
- RNJSJPFDMYEHPI-UHFFFAOYSA-N 3-[(2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC=C(C)C(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1 RNJSJPFDMYEHPI-UHFFFAOYSA-N 0.000 claims 1
- ZGRPGYLLZKRKOR-UHFFFAOYSA-N 3-[(2,6-dichloropyridin-4-yl)carbamoylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)NC1=CC(Cl)=NC(Cl)=C1 ZGRPGYLLZKRKOR-UHFFFAOYSA-N 0.000 claims 1
- MTVCHEWHEXHTEZ-UHFFFAOYSA-N 3-[(2-acetamido-4-methyl-1,3-thiazol-5-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(NC(=O)C)=NC(C)=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MTVCHEWHEXHTEZ-UHFFFAOYSA-N 0.000 claims 1
- QVLVSABXWWUYHH-UHFFFAOYSA-N 3-[(2-acetyloxy-4-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1OC(C)=O QVLVSABXWWUYHH-UHFFFAOYSA-N 0.000 claims 1
- MELIEJQIWWYFQN-UHFFFAOYSA-N 3-[(2-bromo-4-methylbenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1Br MELIEJQIWWYFQN-UHFFFAOYSA-N 0.000 claims 1
- GZNQIZXDGFRFOT-UHFFFAOYSA-N 3-[(2-chloro-4-cyanophenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(=CC=2)C#N)Cl)=C(C(O)=O)S1 GZNQIZXDGFRFOT-UHFFFAOYSA-N 0.000 claims 1
- IGPCFSATFFOOAW-UHFFFAOYSA-N 3-[(2-chlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=CC=C1Cl IGPCFSATFFOOAW-UHFFFAOYSA-N 0.000 claims 1
- XTCZVASLMQSYTG-UHFFFAOYSA-N 3-[(2-chlorophenyl)methyl-(2-methylpropanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C(C)C)CC1=CC=CC=C1Cl XTCZVASLMQSYTG-UHFFFAOYSA-N 0.000 claims 1
- NOWYSEONYZIDTQ-UHFFFAOYSA-N 3-[(2-cyanophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1C#N NOWYSEONYZIDTQ-UHFFFAOYSA-N 0.000 claims 1
- RBRIBDVYHLVUON-UHFFFAOYSA-N 3-[(2-fluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1F RBRIBDVYHLVUON-UHFFFAOYSA-N 0.000 claims 1
- DMGHYWRXWFZGDZ-UHFFFAOYSA-N 3-[(2-hydroxy-4-methylbenzoyl)-propan-2-ylamino]-5-(3-methylphenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C)C=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1O DMGHYWRXWFZGDZ-UHFFFAOYSA-N 0.000 claims 1
- WLANPLOSJUTPJY-UHFFFAOYSA-N 3-[(2-methoxy-4-methylbenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound COC1=CC(C)=CC=C1C(=O)N(C)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 WLANPLOSJUTPJY-UHFFFAOYSA-N 0.000 claims 1
- CUHQPXASHRRGHN-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(3-nitrophenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1 CUHQPXASHRRGHN-UHFFFAOYSA-N 0.000 claims 1
- HHSIYAYAFUPSSR-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-(4-nitrophenyl)thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)[N+]([O-])=O)=C1 HHSIYAYAFUPSSR-UHFFFAOYSA-N 0.000 claims 1
- JHRUSQWNTIPXBE-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(OC(F)(F)F)=CC=2)=C1 JHRUSQWNTIPXBE-UHFFFAOYSA-N 0.000 claims 1
- LPMCPDOXHWVFPI-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-pyridin-4-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CN=CC=2)=C1 LPMCPDOXHWVFPI-UHFFFAOYSA-N 0.000 claims 1
- KUTYVKIVEHCFFR-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-quinolin-8-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C3=NC=CC=C3C=CC=2)=C1 KUTYVKIVEHCFFR-UHFFFAOYSA-N 0.000 claims 1
- MFENFKZQCXNTBM-UHFFFAOYSA-N 3-[(2-methylphenyl)sulfonylamino]-5-thiophen-2-ylthiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2SC=CC=2)=C1 MFENFKZQCXNTBM-UHFFFAOYSA-N 0.000 claims 1
- IZHPXYFZBISFBL-UHFFFAOYSA-N 3-[(2-nitrophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1[N+]([O-])=O IZHPXYFZBISFBL-UHFFFAOYSA-N 0.000 claims 1
- RCTWLZKPLKYHAX-UHFFFAOYSA-N 3-[(3,5-dichlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC(Cl)=CC(Cl)=C1 RCTWLZKPLKYHAX-UHFFFAOYSA-N 0.000 claims 1
- WUTORWIFOQXIBF-UHFFFAOYSA-N 3-[(3-chlorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC(Cl)=C1 WUTORWIFOQXIBF-UHFFFAOYSA-N 0.000 claims 1
- WBYYVLDPSBBWFU-UHFFFAOYSA-N 3-[(3-methoxyphenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound COC1=CC=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(CC(C)C)=CC=2)C(O)=O)=C1 WBYYVLDPSBBWFU-UHFFFAOYSA-N 0.000 claims 1
- CVTMSIYBJXFHGM-UHFFFAOYSA-N 3-[(4-acetylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C(=O)C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 CVTMSIYBJXFHGM-UHFFFAOYSA-N 0.000 claims 1
- LEODRNGNBAXRFL-UHFFFAOYSA-N 3-[(4-aminocyclohexyl)-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1CC(N)CCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl LEODRNGNBAXRFL-UHFFFAOYSA-N 0.000 claims 1
- NPHGTPWRVSUVKU-UHFFFAOYSA-N 3-[(4-bromo-2,5-difluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC(F)=C(Br)C=C1F NPHGTPWRVSUVKU-UHFFFAOYSA-N 0.000 claims 1
- GKLNNFFOCNPDBM-UHFFFAOYSA-N 3-[(4-bromo-2-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC(Br)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 GKLNNFFOCNPDBM-UHFFFAOYSA-N 0.000 claims 1
- BTXQBCGQEMMGGL-UHFFFAOYSA-N 3-[(4-bromo-3-methylbenzoyl)-methylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(Br)C(C)=C1 BTXQBCGQEMMGGL-UHFFFAOYSA-N 0.000 claims 1
- ZZQWZFBHGGEYGU-UHFFFAOYSA-N 3-[(4-chloro-2,5-difluorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC(F)=C(Cl)C=C1F ZZQWZFBHGGEYGU-UHFFFAOYSA-N 0.000 claims 1
- BMWYCRYHUCPJQB-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonyl-[(3-iodophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)N(CC=2C=C(I)C=CC=2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1C BMWYCRYHUCPJQB-UHFFFAOYSA-N 0.000 claims 1
- CDEZPEKCNFPDPF-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-(4-chlorophenyl)thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=CC(Cl)=CC=2)C(O)=O)=C1C CDEZPEKCNFPDPF-UHFFFAOYSA-N 0.000 claims 1
- NXUAAIVUPKHHNC-UHFFFAOYSA-N 3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=CC(NS(=O)(=O)C=2C(=CC(Cl)=C(C)C=2)C)=C(C(O)=O)S1 NXUAAIVUPKHHNC-UHFFFAOYSA-N 0.000 claims 1
- MNHXBYXMXSZEQV-UHFFFAOYSA-N 3-[(4-chloro-2-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=CC(Cl)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 MNHXBYXMXSZEQV-UHFFFAOYSA-N 0.000 claims 1
- LSCILVWEAWFOQC-UHFFFAOYSA-N 3-[(4-chlorobenzoyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1 LSCILVWEAWFOQC-UHFFFAOYSA-N 0.000 claims 1
- KTPKHNIYXBYFFK-UHFFFAOYSA-N 3-[(4-chlorophenoxy)carbonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)OC1=CC=C(Cl)C=C1 KTPKHNIYXBYFFK-UHFFFAOYSA-N 0.000 claims 1
- MSRUNTZECAKRGF-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-(3-nitrophenyl)thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)[N+]([O-])=O)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 MSRUNTZECAKRGF-UHFFFAOYSA-N 0.000 claims 1
- KYOISTWIOPIACA-UHFFFAOYSA-N 3-[(4-methylcyclohexanecarbonyl)-propan-2-ylamino]-5-[3-(trifluoromethyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C(F)(F)F)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCC(C)CC1 KYOISTWIOPIACA-UHFFFAOYSA-N 0.000 claims 1
- NJYCOGNPAOHBPY-UHFFFAOYSA-N 3-[(4-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 NJYCOGNPAOHBPY-UHFFFAOYSA-N 0.000 claims 1
- KLAMXZNISQBFKZ-UHFFFAOYSA-N 3-[(4-methylphenyl)sulfonylamino]-5-thiophen-3-ylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C2=CSC=C2)=C1 KLAMXZNISQBFKZ-UHFFFAOYSA-N 0.000 claims 1
- FAOVOPXOPFMDLA-UHFFFAOYSA-N 3-[(4-pentylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(CCCCC)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 FAOVOPXOPFMDLA-UHFFFAOYSA-N 0.000 claims 1
- DWLCWYANOKPLKD-UHFFFAOYSA-N 3-[(5-carboxy-4-chloro-2-fluorophenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC(C(O)=O)=C(Cl)C=C1F DWLCWYANOKPLKD-UHFFFAOYSA-N 0.000 claims 1
- SGMXHMLWWXNORW-UHFFFAOYSA-N 3-[(5-chloro-3-methyl-1-benzothiophen-2-yl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C2=CC=C(Cl)C=C2C(C)=C1S(=O)(=O)NC(=C(S1)C(O)=O)C=C1C1=CC=CC=C1 SGMXHMLWWXNORW-UHFFFAOYSA-N 0.000 claims 1
- UMKOYEADQOBGPL-UHFFFAOYSA-N 3-[(6-chloropyridine-3-carbonyl)-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)N=C1 UMKOYEADQOBGPL-UHFFFAOYSA-N 0.000 claims 1
- VVQWCIXBRCHDBW-UHFFFAOYSA-N 3-[2-[4-(2,4-difluorobenzoyl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical class CC=1N=C2CCCCN2C(=O)C=1CCN(CC1)CCC1C(=O)C1=CC=C(F)C=C1F VVQWCIXBRCHDBW-UHFFFAOYSA-N 0.000 claims 1
- SELUYVFFCIPMKQ-UHFFFAOYSA-N 3-[2-hydroxyethyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(CCO)C1=C(C(O)=O)SC(C=2C=CC=CC=2)=C1 SELUYVFFCIPMKQ-UHFFFAOYSA-N 0.000 claims 1
- ISWKLMHNNGWPQG-UHFFFAOYSA-N 3-[3-cyclopentylpropanoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC)C(=O)CCC1CCCC1 ISWKLMHNNGWPQG-UHFFFAOYSA-N 0.000 claims 1
- UDISKTQKVACSGP-UHFFFAOYSA-N 3-[3-cyclopentylpropanoyl(methyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C)C(=O)CCC1CCCC1 UDISKTQKVACSGP-UHFFFAOYSA-N 0.000 claims 1
- VASWYPJCUJYIHG-UHFFFAOYSA-N 3-[4-(2-methylpropyl)phenyl]thiophene-2-carboxylic acid Chemical compound C1=CC(CC(C)C)=CC=C1C1=C(C(O)=O)SC=C1 VASWYPJCUJYIHG-UHFFFAOYSA-N 0.000 claims 1
- NMIYLWWSHNJBRE-UHFFFAOYSA-N 3-[4-methylpentanoyl(prop-2-enyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(CC=C)C(=O)CCC(C)C)C=C1C1=CC=CC=C1 NMIYLWWSHNJBRE-UHFFFAOYSA-N 0.000 claims 1
- DLBRFNKHNQCTCE-UHFFFAOYSA-N 3-[[1-(4-methoxy-2,3,6-trimethylphenyl)sulfonyl-5-methyl-3,6-dihydro-2h-pyridine-2-carbonyl]-propan-2-ylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound CC1=C(C)C(OC)=CC(C)=C1S(=O)(=O)N1C(C(=O)N(C(C)C)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)CC=C(C)C1 DLBRFNKHNQCTCE-UHFFFAOYSA-N 0.000 claims 1
- NJIMWAZVNPVZJO-UHFFFAOYSA-N 3-[[2-[2,3-difluoro-4-(trifluoromethyl)phenyl]-2-oxoethyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NCC(=O)C1=CC=C(C(F)(F)F)C(F)=C1F NJIMWAZVNPVZJO-UHFFFAOYSA-N 0.000 claims 1
- TVZQQBXPOAOCMB-UHFFFAOYSA-N 3-[[3-(1-benzofuran-2-yl)phenyl]methyl-(4-chloro-2,5-dimethylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)N(CC=2C=C(C=CC=2)C=2OC3=CC=CC=C3C=2)C2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=C1C TVZQQBXPOAOCMB-UHFFFAOYSA-N 0.000 claims 1
- SFGJKHXPKGLQQB-UHFFFAOYSA-N 3-[[4-(3-chlorophenyl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NC(=O)N(CC1)CCN1C1=CC=CC(Cl)=C1 SFGJKHXPKGLQQB-UHFFFAOYSA-N 0.000 claims 1
- VTZBPZJLPDUCKK-UHFFFAOYSA-N 3-[[4-(4-methoxyphenyl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(OC)=CC=C1N1CCN(C(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)CC1 VTZBPZJLPDUCKK-UHFFFAOYSA-N 0.000 claims 1
- OETHKSLBGKXPAZ-UHFFFAOYSA-N 3-[[4-(6-methylpyridin-2-yl)piperazine-1-carbonyl]amino]-5-phenylthiophene-2-carboxylic acid;hydrochloride Chemical compound Cl.CC1=CC=CC(N2CCN(CC2)C(=O)NC2=C(SC(=C2)C=2C=CC=CC=2)C(O)=O)=N1 OETHKSLBGKXPAZ-UHFFFAOYSA-N 0.000 claims 1
- VNDHIIJYVXDSKW-UHFFFAOYSA-N 3-[[4-fluoro-2-(trifluoromethyl)phenyl]sulfonylamino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(F)C=C1C(F)(F)F VNDHIIJYVXDSKW-UHFFFAOYSA-N 0.000 claims 1
- KIJFEBKOVJOMNT-UHFFFAOYSA-N 3-[[5-(1-benzofuran-2-yl)thiophen-2-yl]methyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(CC=1SC(=CC=1)C=1OC2=CC=CC=C2C=1)C(=O)C1=CC=C(Cl)C=C1Cl KIJFEBKOVJOMNT-UHFFFAOYSA-N 0.000 claims 1
- LKWMMBTWAYSOTJ-UHFFFAOYSA-N 3-[acetyl-[(2-methylphenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)C)CC1=CC=CC=C1C LKWMMBTWAYSOTJ-UHFFFAOYSA-N 0.000 claims 1
- ITAXGIVXOBBIGO-UHFFFAOYSA-N 3-[benzyl(propanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(=O)CC)CC1=CC=CC=C1 ITAXGIVXOBBIGO-UHFFFAOYSA-N 0.000 claims 1
- SIIMIVJATFOKHR-UHFFFAOYSA-N 3-[benzyl-(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=CC(C)=CC=C1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)CC1=CC=CC=C1 SIIMIVJATFOKHR-UHFFFAOYSA-N 0.000 claims 1
- PWPCCXSZLFVANL-UHFFFAOYSA-N 3-[butanoyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(CC)C(=O)CCC)C=C1C1=CC=CC=C1 PWPCCXSZLFVANL-UHFFFAOYSA-N 0.000 claims 1
- YUIZNFJAQDNHFE-UHFFFAOYSA-N 3-[butanoyl(methyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CCC)C=C1C1=CC=CC=C1 YUIZNFJAQDNHFE-UHFFFAOYSA-N 0.000 claims 1
- AREJGCOZUYGPKP-UHFFFAOYSA-N 3-[cycloheptanecarbonyl(propan-2-yl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1CCCCCC1 AREJGCOZUYGPKP-UHFFFAOYSA-N 0.000 claims 1
- JNMLHKVIANKLAW-UHFFFAOYSA-N 3-[cyclohexanecarbonyl-[(2,4-difluorophenyl)methyl]amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C1CCCCC1)CC1=CC=C(F)C=C1F JNMLHKVIANKLAW-UHFFFAOYSA-N 0.000 claims 1
- GJOFSMPASDURJR-UHFFFAOYSA-N 3-[cyclopentanecarbonyl(ethyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(CC)C(=O)C1CCCC1 GJOFSMPASDURJR-UHFFFAOYSA-N 0.000 claims 1
- VVWRGFRAROIXHC-UHFFFAOYSA-N 3-[cyclopropyl-(2,4-dichlorobenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1N(C(=O)C=1C(=CC(Cl)=CC=1)Cl)C1CC1 VVWRGFRAROIXHC-UHFFFAOYSA-N 0.000 claims 1
- JKZZIRPULQQELF-UHFFFAOYSA-N 3-[ethyl(hexanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(CC)C(=O)CCCCC)C=C1C1=CC=CC=C1 JKZZIRPULQQELF-UHFFFAOYSA-N 0.000 claims 1
- LRHXIDOGMBZJFN-UHFFFAOYSA-N 3-[isopropyl(4-methylbenzoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC=CC=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(C)C=C1 LRHXIDOGMBZJFN-UHFFFAOYSA-N 0.000 claims 1
- HOEWJRXSNBUUSG-UHFFFAOYSA-N 3-[methyl(3-methylbutanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CC(C)C)C=C1C1=CC=CC=C1 HOEWJRXSNBUUSG-UHFFFAOYSA-N 0.000 claims 1
- ZITWCPNLBDEOGY-UHFFFAOYSA-N 3-[methyl(4-methylpentanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CCC(C)C)C=C1C1=CC=CC=C1 ZITWCPNLBDEOGY-UHFFFAOYSA-N 0.000 claims 1
- NINFPMVAAVXRND-UHFFFAOYSA-N 3-[methyl(pent-4-enoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C(=O)CCC=C)C)C=C1C1=CC=CC=C1 NINFPMVAAVXRND-UHFFFAOYSA-N 0.000 claims 1
- RWQSABWWSQCRRJ-UHFFFAOYSA-N 3-[methyl(pentanoyl)amino]-5-phenylthiophene-2-carboxylic acid Chemical compound S1C(C(O)=O)=C(N(C)C(=O)CCCC)C=C1C1=CC=CC=C1 RWQSABWWSQCRRJ-UHFFFAOYSA-N 0.000 claims 1
- KNEVFAXLOQHQSZ-UHFFFAOYSA-N 3-[methyl-(4-methylbenzoyl)amino]-5-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(OC(F)(F)F)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 KNEVFAXLOQHQSZ-UHFFFAOYSA-N 0.000 claims 1
- NIXGYRHZQFZCCV-UHFFFAOYSA-N 4,6-dichloro-1h-indole Chemical compound ClC1=CC(Cl)=C2C=CNC2=C1 NIXGYRHZQFZCCV-UHFFFAOYSA-N 0.000 claims 1
- WYFCZWSWFGJODV-MIANJLSGSA-N 4-[[(1s)-2-[(e)-3-[3-chloro-2-fluoro-6-(tetrazol-1-yl)phenyl]prop-2-enoyl]-5-(4-methyl-2-oxopiperazin-1-yl)-3,4-dihydro-1h-isoquinoline-1-carbonyl]amino]benzoic acid Chemical compound O=C1CN(C)CCN1C1=CC=CC2=C1CCN(C(=O)\C=C\C=1C(=CC=C(Cl)C=1F)N1N=NN=C1)[C@@H]2C(=O)NC1=CC=C(C(O)=O)C=C1 WYFCZWSWFGJODV-MIANJLSGSA-N 0.000 claims 1
- MPMKMQHJHDHPBE-RUZDIDTESA-N 4-[[(2r)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid Chemical compound O=C([C@@]1(N(CC1)C(=O)C=1C2=CC=CC=C2SC=1)C)N(CCCC(O)=O)CC1=CC=CC(Cl)=C1 MPMKMQHJHDHPBE-RUZDIDTESA-N 0.000 claims 1
- GVCLNACSYKYUHP-UHFFFAOYSA-N 4-amino-7-(2-hydroxyethoxymethyl)pyrrolo[2,3-d]pyrimidine-5-carbothioamide Chemical compound C1=NC(N)=C2C(C(=S)N)=CN(COCCO)C2=N1 GVCLNACSYKYUHP-UHFFFAOYSA-N 0.000 claims 1
- GSDQYSSLIKJJOG-UHFFFAOYSA-N 4-chloro-2-(3-chloroanilino)benzoic acid Chemical compound OC(=O)C1=CC=C(Cl)C=C1NC1=CC=CC(Cl)=C1 GSDQYSSLIKJJOG-UHFFFAOYSA-N 0.000 claims 1
- DQGRGHAKEZFOLQ-UHFFFAOYSA-N 5-(1-benzofuran-2-yl)-3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2OC3=CC=CC=C3C=2)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl DQGRGHAKEZFOLQ-UHFFFAOYSA-N 0.000 claims 1
- IGCSUFXXOYVNSW-UHFFFAOYSA-N 5-(2,4-difluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C(=CC(F)=CC=2)F)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 IGCSUFXXOYVNSW-UHFFFAOYSA-N 0.000 claims 1
- MVTPFJTZGZQLSW-UHFFFAOYSA-N 5-(2-chlorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C(=CC=CC=2)Cl)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 MVTPFJTZGZQLSW-UHFFFAOYSA-N 0.000 claims 1
- RYRMGCIYEBUIHY-UHFFFAOYSA-N 5-(2-hydroxyphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C(=CC=CC=2)O)=C1 RYRMGCIYEBUIHY-UHFFFAOYSA-N 0.000 claims 1
- UBAKMPJZPGNBRL-UHFFFAOYSA-N 5-(3,5-difluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(F)C=C(F)C=2)=C1 UBAKMPJZPGNBRL-UHFFFAOYSA-N 0.000 claims 1
- HTZLXJVFYOWLRB-UHFFFAOYSA-N 5-(3-chlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(Cl)C=CC=2)=C1 HTZLXJVFYOWLRB-UHFFFAOYSA-N 0.000 claims 1
- MHNIOOCUIUVFKK-UHFFFAOYSA-N 5-(3-cyanophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(C=CC=2)C#N)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 MHNIOOCUIUVFKK-UHFFFAOYSA-N 0.000 claims 1
- NNFNYSAHMPRLBE-UHFFFAOYSA-N 5-(3-ethoxycarbonylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CCOC(=O)C1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 NNFNYSAHMPRLBE-UHFFFAOYSA-N 0.000 claims 1
- GXTVADHMXNLCAB-UHFFFAOYSA-N 5-(3-fluorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=C(F)C=CC=2)=C1 GXTVADHMXNLCAB-UHFFFAOYSA-N 0.000 claims 1
- FZKZVSZPPCMPLQ-UHFFFAOYSA-N 5-(3-fluorophenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=C(F)C=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 FZKZVSZPPCMPLQ-UHFFFAOYSA-N 0.000 claims 1
- ZFZJJUVWTSSAKV-UHFFFAOYSA-N 5-(3-methylphenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 ZFZJJUVWTSSAKV-UHFFFAOYSA-N 0.000 claims 1
- ONGONNHGDVUCGB-UHFFFAOYSA-N 5-(4-azidophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)N=[N+]=[N-])=C1 ONGONNHGDVUCGB-UHFFFAOYSA-N 0.000 claims 1
- PUVKRADPVJZRBA-UHFFFAOYSA-N 5-(4-carbamoylphenyl)-3-[(2,4-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C(N)=O)=C1 PUVKRADPVJZRBA-UHFFFAOYSA-N 0.000 claims 1
- HFAHCVUDNFLEHU-UHFFFAOYSA-N 5-(4-carboxyphenyl)-3-[(2,4-dichlorobenzoyl)-propan-2-ylamino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(=CC=2)C(O)=O)SC(C(O)=O)=C1N(C(C)C)C(=O)C1=CC=C(Cl)C=C1Cl HFAHCVUDNFLEHU-UHFFFAOYSA-N 0.000 claims 1
- IVEHHMJVVPJWPX-UHFFFAOYSA-N 5-(4-chlorophenyl)-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(Cl)=CC=2)=C1 IVEHHMJVVPJWPX-UHFFFAOYSA-N 0.000 claims 1
- FTQNYPUMXTXFLP-UHFFFAOYSA-N 5-(4-cyanophenyl)-3-[(2,4-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2C=CC(=CC=2)C#N)=C1 FTQNYPUMXTXFLP-UHFFFAOYSA-N 0.000 claims 1
- WITUCJBPBKKQCP-UHFFFAOYSA-N 5-(4-hydroxyphenyl)-3-[methyl-(4-methylbenzoyl)amino]thiophene-2-carboxylic acid Chemical compound C1=C(C=2C=CC(O)=CC=2)SC(C(O)=O)=C1N(C)C(=O)C1=CC=C(C)C=C1 WITUCJBPBKKQCP-UHFFFAOYSA-N 0.000 claims 1
- QIPDHDRHVPDMEH-UHFFFAOYSA-N 5-[3,5-bis(trifluoromethyl)phenyl]-3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)C(O)=O)=C1C QIPDHDRHVPDMEH-UHFFFAOYSA-N 0.000 claims 1
- REWIXVLKDUVROC-UHFFFAOYSA-N 5-[5-carboxy-4-[(2-methylphenyl)sulfonylamino]thiophen-2-yl]-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C=2SC(=C(NS(=O)(=O)C=3C(=CC=CC=3)C)C=2)C(O)=O)=C1 REWIXVLKDUVROC-UHFFFAOYSA-N 0.000 claims 1
- VKLKXFOZNHEBSW-UHFFFAOYSA-N 5-[[3-[(4-morpholin-4-ylbenzoyl)amino]phenyl]methoxy]pyridine-3-carboxamide Chemical compound O1CCN(CC1)C1=CC=C(C(=O)NC=2C=C(COC=3C=NC=C(C(=O)N)C=3)C=CC=2)C=C1 VKLKXFOZNHEBSW-UHFFFAOYSA-N 0.000 claims 1
- BLIIUTNQTSUELU-UHFFFAOYSA-N 5-benzoyl-3-[(2-methylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound CC1=CC=CC=C1S(=O)(=O)NC1=C(C(O)=O)SC(C(=O)C=2C=CC=CC=2)=C1 BLIIUTNQTSUELU-UHFFFAOYSA-N 0.000 claims 1
- IJRKLHTZAIFUTB-UHFFFAOYSA-N 5-nitro-2-(2-phenylethylamino)benzoic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC=C1NCCC1=CC=CC=C1 IJRKLHTZAIFUTB-UHFFFAOYSA-N 0.000 claims 1
- RVACAOYDDPOVDD-UHFFFAOYSA-N 5-phenyl-3-(pyridin-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=N1 RVACAOYDDPOVDD-UHFFFAOYSA-N 0.000 claims 1
- FCJOOCHSXUKBHV-UHFFFAOYSA-N 5-phenyl-3-(thiophen-2-ylsulfonylamino)thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CS1 FCJOOCHSXUKBHV-UHFFFAOYSA-N 0.000 claims 1
- QBDOORCNWOANLI-UHFFFAOYSA-N 5-phenyl-3-[(2,3,4-trifluorophenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(F)C(F)=C1F QBDOORCNWOANLI-UHFFFAOYSA-N 0.000 claims 1
- CLGGAOUGQBNDGK-UHFFFAOYSA-N 5-phenyl-3-[[2-(trifluoromethoxy)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1OC(F)(F)F CLGGAOUGQBNDGK-UHFFFAOYSA-N 0.000 claims 1
- YVZWGWVMODRXBK-UHFFFAOYSA-N 5-phenyl-3-[[2-(trifluoromethyl)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC=C1C(F)(F)F YVZWGWVMODRXBK-UHFFFAOYSA-N 0.000 claims 1
- DPPKPVVUOUFOOS-UHFFFAOYSA-N 5-phenyl-3-[[3-(trifluoromethyl)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=CC(C(F)(F)F)=C1 DPPKPVVUOUFOOS-UHFFFAOYSA-N 0.000 claims 1
- HTXTXXLYPFNSFB-UHFFFAOYSA-N 5-phenyl-3-[[4-(trifluoromethyl)phenyl]sulfonylamino]thiophene-2-carboxylic acid Chemical compound OC(=O)C=1SC(C=2C=CC=CC=2)=CC=1NS(=O)(=O)C1=CC=C(C(F)(F)F)C=C1 HTXTXXLYPFNSFB-UHFFFAOYSA-N 0.000 claims 1
- PUUUHPKNOUPVDT-UHFFFAOYSA-N 5-tert-butyl-3-[(4-chloro-2,5-dimethylphenyl)sulfonylamino]thiophene-2-carboxylic acid Chemical compound C1=C(Cl)C(C)=CC(S(=O)(=O)NC2=C(SC(=C2)C(C)(C)C)C(O)=O)=C1C PUUUHPKNOUPVDT-UHFFFAOYSA-N 0.000 claims 1
- PTNWHEHDBNNKEO-UHFFFAOYSA-N 5-thiophen-2-ylthiophene-2-carboxylic acid Chemical compound S1C(C(=O)O)=CC=C1C1=CC=CS1 PTNWHEHDBNNKEO-UHFFFAOYSA-N 0.000 claims 1
- GDUANFXPOZTYKS-UHFFFAOYSA-N 6-bromo-8-[(2,6-difluoro-4-methoxybenzoyl)amino]-4-oxochromene-2-carboxylic acid Chemical compound FC1=CC(OC)=CC(F)=C1C(=O)NC1=CC(Br)=CC2=C1OC(C(O)=O)=CC2=O GDUANFXPOZTYKS-UHFFFAOYSA-N 0.000 claims 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 claims 1
- IYHHRZBKXXKDDY-UHFFFAOYSA-N BI-605906 Chemical compound N=1C=2SC(C(N)=O)=C(N)C=2C(C(F)(F)CC)=CC=1N1CCC(S(C)(=O)=O)CC1 IYHHRZBKXXKDDY-UHFFFAOYSA-N 0.000 claims 1
- BGGALFIXXQOTPY-NRFANRHFSA-N C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC Chemical compound C1(=C(C2=C(C=C1)N(C(C#N)=C2)C[C@@H](N1CCN(CC1)S(=O)(=O)C)C)C)CN1CCC(CC1)NC1=NC(=NC2=C1C=C(S2)CC(F)(F)F)NC BGGALFIXXQOTPY-NRFANRHFSA-N 0.000 claims 1
- PKMUHQIDVVOXHQ-HXUWFJFHSA-N C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O Chemical compound C[C@H](C1=CC(C2=CC=C(CNC3CCCC3)S2)=CC=C1)NC(C1=C(C)C=CC(NC2CNC2)=C1)=O PKMUHQIDVVOXHQ-HXUWFJFHSA-N 0.000 claims 1
- XVZXOLOFWKSDSR-UHFFFAOYSA-N Cc1cc(C)c([C]=O)c(C)c1 Chemical class Cc1cc(C)c([C]=O)c(C)c1 XVZXOLOFWKSDSR-UHFFFAOYSA-N 0.000 claims 1
- RAPBNVDSDCTNRC-UHFFFAOYSA-N Chlorobenzilate Chemical compound C=1C=C(Cl)C=CC=1C(O)(C(=O)OCC)C1=CC=C(Cl)C=C1 RAPBNVDSDCTNRC-UHFFFAOYSA-N 0.000 claims 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 claims 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 claims 1
- 208000005176 Hepatitis C Diseases 0.000 claims 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims 1
- FPGUZFDAMDZABU-UHFFFAOYSA-N N,4-dimethyl-N-(5-pyridin-3-ylthiophen-3-yl)benzamide Chemical compound CN(C1=CSC(=C1)C=1C=NC=CC=1)C(C1=CC=C(C=C1)C)=O FPGUZFDAMDZABU-UHFFFAOYSA-N 0.000 claims 1
- LIMFPAAAIVQRRD-BCGVJQADSA-N N-[2-[(3S,4R)-3-fluoro-4-methoxypiperidin-1-yl]pyrimidin-4-yl]-8-[(2R,3S)-2-methyl-3-(methylsulfonylmethyl)azetidin-1-yl]-5-propan-2-ylisoquinolin-3-amine Chemical compound F[C@H]1CN(CC[C@H]1OC)C1=NC=CC(=N1)NC=1N=CC2=C(C=CC(=C2C=1)C(C)C)N1[C@@H]([C@H](C1)CS(=O)(=O)C)C LIMFPAAAIVQRRD-BCGVJQADSA-N 0.000 claims 1
- CLCTZVRHDOAUGJ-UHFFFAOYSA-N N-[4-(3-chloro-4-cyanophenoxy)cyclohexyl]-6-[4-[[4-[2-(2,6-dioxopiperidin-3-yl)-6-fluoro-1,3-dioxoisoindol-5-yl]piperazin-1-yl]methyl]piperidin-1-yl]pyridazine-3-carboxamide Chemical compound FC1=CC2=C(C=C1N1CCN(CC3CCN(CC3)C3=CC=C(N=N3)C(=O)NC3CCC(CC3)OC3=CC(Cl)=C(C=C3)C#N)CC1)C(=O)N(C1CCC(=O)NC1=O)C2=O CLCTZVRHDOAUGJ-UHFFFAOYSA-N 0.000 claims 1
- AVYVHIKSFXVDBG-UHFFFAOYSA-N N-benzyl-N-hydroxy-2,2-dimethylbutanamide Chemical compound C(C1=CC=CC=C1)N(C(C(CC)(C)C)=O)O AVYVHIKSFXVDBG-UHFFFAOYSA-N 0.000 claims 1
- POFVJRKJJBFPII-UHFFFAOYSA-N N-cyclopentyl-5-[2-[[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]amino]-5-fluoropyrimidin-4-yl]-4-methyl-1,3-thiazol-2-amine Chemical compound C1(CCCC1)NC=1SC(=C(N=1)C)C1=NC(=NC=C1F)NC1=NC=C(C=C1)CN1CCN(CC1)CC POFVJRKJJBFPII-UHFFFAOYSA-N 0.000 claims 1
- 239000000026 Pentaerythritol tetranitrate Substances 0.000 claims 1
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 claims 1
- RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical class OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 claims 1
- SPXSEZMVRJLHQG-XMMPIXPASA-N [(2R)-1-[[4-[(3-phenylmethoxyphenoxy)methyl]phenyl]methyl]pyrrolidin-2-yl]methanol Chemical compound C(C1=CC=CC=C1)OC=1C=C(OCC2=CC=C(CN3[C@H](CCC3)CO)C=C2)C=CC=1 SPXSEZMVRJLHQG-XMMPIXPASA-N 0.000 claims 1
- DRBWRJPFNOBNIO-KOLCDFICSA-N [(2r)-1-[(2r)-2-(pyridine-4-carbonylamino)propanoyl]pyrrolidin-2-yl]boronic acid Chemical compound N([C@H](C)C(=O)N1[C@@H](CCC1)B(O)O)C(=O)C1=CC=NC=C1 DRBWRJPFNOBNIO-KOLCDFICSA-N 0.000 claims 1
- YGPZYYDTPXVBRA-RTDBHSBRSA-N [(2r,3s,4r,5r,6s)-2-[[(2r,3r,4r,5s,6r)-3-[[(3r)-3-dodecanoyloxytetradecanoyl]amino]-6-(hydroxymethyl)-5-phosphonooxy-4-[(3r)-3-tetradecanoyloxytetradecanoyl]oxyoxan-2-yl]oxymethyl]-3,6-dihydroxy-5-[[(3r)-3-hydroxytetradecanoyl]amino]oxan-4-yl] (3r)-3-hydr Chemical compound O1[C@H](CO)[C@@H](OP(O)(O)=O)[C@H](OC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCCCC)[C@@H](NC(=O)C[C@@H](CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)[C@@H]1OC[C@@H]1[C@@H](O)[C@H](OC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](NC(=O)C[C@H](O)CCCCCCCCCCC)[C@@H](O)O1 YGPZYYDTPXVBRA-RTDBHSBRSA-N 0.000 claims 1
- PSLUFJFHTBIXMW-WYEYVKMPSA-N [(3r,4ar,5s,6s,6as,10s,10ar,10bs)-3-ethenyl-10,10b-dihydroxy-3,4a,7,7,10a-pentamethyl-1-oxo-6-(2-pyridin-2-ylethylcarbamoyloxy)-5,6,6a,8,9,10-hexahydro-2h-benzo[f]chromen-5-yl] acetate Chemical compound O([C@@H]1[C@@H]([C@]2(O[C@](C)(CC(=O)[C@]2(O)[C@@]2(C)[C@@H](O)CCC(C)(C)[C@@H]21)C=C)C)OC(=O)C)C(=O)NCCC1=CC=CC=N1 PSLUFJFHTBIXMW-WYEYVKMPSA-N 0.000 claims 1
- KNOCDBZPOREEQE-UHFFFAOYSA-N [2-[(2-carboxy-5-phenylthiophen-3-yl)-(2,4-dichlorobenzoyl)amino]cyclohexyl]azanium;chloride Chemical compound [Cl-].[NH3+]C1CCCCC1N(C1=C(SC(=C1)C=1C=CC=CC=1)C(O)=O)C(=O)C1=CC=C(Cl)C=C1Cl KNOCDBZPOREEQE-UHFFFAOYSA-N 0.000 claims 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 claims 1
- 229940125364 angiotensin receptor blocker Drugs 0.000 claims 1
- MEOZFUYXLCDYGA-UHFFFAOYSA-N azepane-1-carboxylic acid Chemical compound OC(=O)N1CCCCCC1 MEOZFUYXLCDYGA-UHFFFAOYSA-N 0.000 claims 1
- 125000003725 azepanyl group Chemical group 0.000 claims 1
- 125000002393 azetidinyl group Chemical group 0.000 claims 1
- 125000004069 aziridinyl group Chemical group 0.000 claims 1
- 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims 1
- KGNDCEVUMONOKF-UGPLYTSKSA-N benzyl n-[(2r)-1-[(2s,4r)-2-[[(2s)-6-amino-1-(1,3-benzoxazol-2-yl)-1,1-dihydroxyhexan-2-yl]carbamoyl]-4-[(4-methylphenyl)methoxy]pyrrolidin-1-yl]-1-oxo-4-phenylbutan-2-yl]carbamate Chemical compound C1=CC(C)=CC=C1CO[C@H]1CN(C(=O)[C@@H](CCC=2C=CC=CC=2)NC(=O)OCC=2C=CC=CC=2)[C@H](C(=O)N[C@@H](CCCCN)C(O)(O)C=2OC3=CC=CC=C3N=2)C1 KGNDCEVUMONOKF-UGPLYTSKSA-N 0.000 claims 1
- 239000004305 biphenyl Substances 0.000 claims 1
- 235000010290 biphenyl Nutrition 0.000 claims 1
- 125000000068 chlorophenyl group Chemical group 0.000 claims 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000004188 dichlorophenyl group Chemical group 0.000 claims 1
- 125000000532 dioxanyl group Chemical group 0.000 claims 1
- 150000002084 enol ethers Chemical class 0.000 claims 1
- BJXYHBKEQFQVES-NWDGAFQWSA-N enpatoran Chemical compound N[C@H]1CN(C[C@H](C1)C(F)(F)F)C1=C2C=CC=NC2=C(C=C1)C#N BJXYHBKEQFQVES-NWDGAFQWSA-N 0.000 claims 1
- 150000004678 hydrides Chemical class 0.000 claims 1
- 125000003454 indenyl group Chemical group C1(C=CC2=CC=CC=C12)* 0.000 claims 1
- 229910003002 lithium salt Inorganic materials 0.000 claims 1
- LBGLFEUKGFLLOB-UHFFFAOYSA-M lithium;3-[(4-methylcyclohexanecarbonyl)-piperidin-4-ylamino]-5-phenylthiophene-2-carboxylate Chemical compound [Li+].C1CC(C)CCC1C(=O)N(C1=C(SC(=C1)C=1C=CC=CC=1)C([O-])=O)C1CCNCC1 LBGLFEUKGFLLOB-UHFFFAOYSA-M 0.000 claims 1
- RENRQMCACQEWFC-UGKGYDQZSA-N lnp023 Chemical compound C1([C@H]2N(CC=3C=4C=CNC=4C(C)=CC=3OC)CC[C@@H](C2)OCC)=CC=C(C(O)=O)C=C1 RENRQMCACQEWFC-UGKGYDQZSA-N 0.000 claims 1
- JIQNWFBLYKVZFY-UHFFFAOYSA-N methoxycyclohexatriene Chemical class COC1=C[C]=CC=C1 JIQNWFBLYKVZFY-UHFFFAOYSA-N 0.000 claims 1
- UAEPNZWRGJTJPN-UHFFFAOYSA-N methylcyclohexane Chemical compound CC1CCCCC1 UAEPNZWRGJTJPN-UHFFFAOYSA-N 0.000 claims 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 claims 1
- FMPDLFJFQAPPGK-UHFFFAOYSA-N n,n-diethyl-1,3-thiazol-2-amine Chemical compound CCN(CC)C1=NC=CS1 FMPDLFJFQAPPGK-UHFFFAOYSA-N 0.000 claims 1
- YGBMCLDVRUGXOV-UHFFFAOYSA-N n-[6-[6-chloro-5-[(4-fluorophenyl)sulfonylamino]pyridin-3-yl]-1,3-benzothiazol-2-yl]acetamide Chemical compound C1=C2SC(NC(=O)C)=NC2=CC=C1C(C=1)=CN=C(Cl)C=1NS(=O)(=O)C1=CC=C(F)C=C1 YGBMCLDVRUGXOV-UHFFFAOYSA-N 0.000 claims 1
- LPOIGVZLNWEGJG-UHFFFAOYSA-N n-benzyl-5-(4-methylpiperazin-1-yl)-2-nitroaniline Chemical compound C1CN(C)CCN1C1=CC=C([N+]([O-])=O)C(NCC=2C=CC=CC=2)=C1 LPOIGVZLNWEGJG-UHFFFAOYSA-N 0.000 claims 1
- PSAFWMWSBUBKNJ-UHFFFAOYSA-N n-cyclobutyl-3-[(4-methylphenyl)sulfonylamino]-5-phenylthiophene-2-carboxamide Chemical compound C1=CC(C)=CC=C1S(=O)(=O)NC1=C(C(=O)NC2CCC2)SC(C=2C=CC=CC=2)=C1 PSAFWMWSBUBKNJ-UHFFFAOYSA-N 0.000 claims 1
- BYQOOVLTUALGDY-UHFFFAOYSA-N naphthalene-2-carboxylic acid Chemical compound C1=C=CC=C2[CH]C(C(=O)O)=CC=C21 BYQOOVLTUALGDY-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- IOMMMLWIABWRKL-WUTDNEBXSA-N nazartinib Chemical compound C1N(C(=O)/C=C/CN(C)C)CCCC[C@H]1N1C2=C(Cl)C=CC=C2N=C1NC(=O)C1=CC=NC(C)=C1 IOMMMLWIABWRKL-WUTDNEBXSA-N 0.000 claims 1
- PIDFDZJZLOTZTM-KHVQSSSXSA-N ombitasvir Chemical compound COC(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1C(=O)NC1=CC=C([C@H]2N([C@@H](CC2)C=2C=CC(NC(=O)[C@H]3N(CCC3)C(=O)[C@@H](NC(=O)OC)C(C)C)=CC=2)C=2C=CC(=CC=2)C(C)(C)C)C=C1 PIDFDZJZLOTZTM-KHVQSSSXSA-N 0.000 claims 1
- 125000002971 oxazolyl group Chemical group 0.000 claims 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 claims 1
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 1
- 125000003944 tolyl group Chemical group 0.000 claims 1
- DJXJARQPGKYVNA-UHFFFAOYSA-N trifluoromethanolate Chemical compound [O-]C(F)(F)F DJXJARQPGKYVNA-UHFFFAOYSA-N 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
- 125000001037 p-tolyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)C([H])([H])[H] 0.000 description 6
- 239000003814 drug Substances 0.000 description 4
- 150000004673 fluoride salts Chemical group 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
- 108010082126 Alanine transaminase Proteins 0.000 description 2
- 241000710780 Bovine viral diarrhea virus 1 Species 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 241000710777 Classical swine fever virus Species 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 241000711549 Hepacivirus C Species 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 101800001019 Non-structural protein 4B Proteins 0.000 description 1
- 101800001014 Non-structural protein 5A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- 108010076039 Polyproteins Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108010067390 Viral Proteins Proteins 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121357 antivirals Drugs 0.000 description 1
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000011284 combination treatment Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 241001493065 dsRNA viruses Species 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000004904 long-term response Effects 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000020978 protein processing Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D333/40—Thiophene-2-carboxylic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D419/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms
- C07D419/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29673101P | 2001-06-11 | 2001-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200309590B true ZA200309590B (en) | 2004-05-12 |
Family
ID=23143308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200309590A ZA200309590B (en) | 2001-06-11 | 2003-12-10 | Thiophene derivatives as antiviral agents for flavivirus infection. |
Country Status (25)
Country | Link |
---|---|
US (2) | US6881741B2 (cs) |
EP (3) | EP1401825B1 (cs) |
JP (2) | JP4544857B2 (cs) |
KR (1) | KR100900304B1 (cs) |
CN (2) | CN100509797C (cs) |
AP (1) | AP1753A (cs) |
AT (1) | ATE438637T1 (cs) |
AU (2) | AU2002344854B2 (cs) |
BR (1) | BR0210357A (cs) |
CA (1) | CA2450007C (cs) |
CY (1) | CY1109497T1 (cs) |
CZ (1) | CZ20033368A3 (cs) |
DE (1) | DE60233227D1 (cs) |
DK (1) | DK1401825T3 (cs) |
EA (1) | EA007484B1 (cs) |
ES (1) | ES2330313T3 (cs) |
MX (1) | MXPA03011452A (cs) |
NO (1) | NO331721B1 (cs) |
OA (1) | OA12622A (cs) |
PL (2) | PL208713B1 (cs) |
PT (1) | PT1401825E (cs) |
SI (1) | SI1401825T1 (cs) |
SK (1) | SK288015B6 (cs) |
WO (1) | WO2002100851A2 (cs) |
ZA (1) | ZA200309590B (cs) |
Families Citing this family (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP1753A (en) * | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
US8329924B2 (en) * | 2001-06-11 | 2012-12-11 | Vertex Pharmaceuticals (Canada) Incorporated | Compounds and methods for the treatment or prevention of Flavivirus infections |
SE0102616D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
WO2003029242A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | NF-λB INHIBITORS |
US7375131B2 (en) * | 2002-06-06 | 2008-05-20 | Smithklinebeecham Corp. | NF-κB inhibitors |
US7179836B2 (en) * | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
TW200418863A (en) * | 2002-10-17 | 2004-10-01 | Upjohn Co | Novel anthelmintic and insecticidal compositions |
US20050075279A1 (en) | 2002-10-25 | 2005-04-07 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
AU2003291885A1 (en) * | 2002-12-10 | 2004-06-30 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
KR101058696B1 (ko) * | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
US20040192707A1 (en) * | 2002-12-10 | 2004-09-30 | Laval Chan Chun Kong | Compounds and methods for the treatment or prevention of Flavivirus infections |
US7365094B2 (en) | 2002-12-23 | 2008-04-29 | 4Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
WO2004056746A1 (en) | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
CA2509138A1 (en) * | 2002-12-23 | 2004-07-08 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
US7247736B2 (en) | 2002-12-23 | 2007-07-24 | 4Sc Ag | Method of identifying inhibitors of DHODH |
SE0300091D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
SE0300092D0 (sv) * | 2003-01-15 | 2003-01-15 | Astrazeneca Ab | Novel compounds |
US7223785B2 (en) | 2003-01-22 | 2007-05-29 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
ES2386161T3 (es) | 2003-04-16 | 2012-08-10 | Bristol-Myers Squibb Company | Proceso para separar una mezcla de enantiómeros de éster alquílico usando una enzima |
US7112601B2 (en) | 2003-09-11 | 2006-09-26 | Bristol-Myers Squibb Company | Cycloalkyl heterocycles for treating hepatitis C virus |
PL1680137T3 (pl) | 2003-10-14 | 2013-04-30 | F Hoffmann La Roche Ltd | Makrocykliczny kwas karboksylowy i związek acylosulfonamidowy jako inhibitor replikacji HCV |
EP1944042A1 (en) * | 2003-10-27 | 2008-07-16 | Vertex Pharmceuticals Incorporated | Combinations for HCV treatment |
DK1677827T3 (da) * | 2003-10-27 | 2009-03-30 | Vertex Pharma | Kombinationer til HCV-behandling |
DE10359791A1 (de) * | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
GB0500020D0 (en) | 2005-01-04 | 2005-02-09 | Novartis Ag | Organic compounds |
KR20120091276A (ko) | 2004-02-20 | 2012-08-17 | 베링거 인겔하임 인터내셔날 게엠베하 | 바이러스 폴리머라제 억제제 |
US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
DE102005028077A1 (de) * | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
DE102004061746A1 (de) * | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
WO2006074025A1 (en) | 2004-12-30 | 2006-07-13 | Janssen Pharmaceutica N.V. | Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
CN101189230A (zh) | 2005-05-04 | 2008-05-28 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒的杂环化合物 |
AU2011205048B2 (en) * | 2005-05-13 | 2013-05-02 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
ES2415742T3 (es) * | 2005-05-13 | 2013-07-26 | Vertex Pharmaceuticals (Canada) Incorporated | Compuestos y procedimientos para el tratamiento o prevención de infecciones por flavivirus |
DE602006003661D1 (de) | 2005-06-06 | 2008-12-24 | Lilly Co Eli | Ampa-rezeptoren-verstärker |
CA2633569A1 (en) * | 2005-12-12 | 2007-06-21 | Genelabs Technologies, Inc. | N-(5-membered heteroaromatic ring)-amido anti-viral compounds |
GB0526255D0 (en) | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
US20090136448A1 (en) * | 2005-12-22 | 2009-05-28 | John Andrew Corfield | Antiviral 2-Carboxy-Thiophene Compounds |
KR20090033881A (ko) * | 2006-07-14 | 2009-04-06 | 제네랩스 테크놀로지스, 인코포레이티드 | 항바이러스제 |
WO2008017688A1 (en) * | 2006-08-11 | 2008-02-14 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti-viral agents |
CA2665804A1 (en) * | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | Urea compound or salt thereof |
EP2361922B1 (en) | 2006-10-10 | 2012-08-22 | Janssen Products, L.P. | Intermediate to HCV-Nucleoside Inhibitors |
WO2008043791A2 (en) * | 2006-10-13 | 2008-04-17 | Smithkline Beecham Corporation | Thiophene derivatives for treating hepatitis c |
EA201101492A1 (ru) * | 2006-11-15 | 2012-09-28 | Вирокем Фарма Инк. | Аналоги тиофена для лечения или предупреждения флавивирусных инфекций |
WO2008059042A1 (en) * | 2006-11-17 | 2008-05-22 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti viral agents |
GB0707092D0 (en) * | 2007-04-12 | 2007-05-23 | Smithkline Beecham Corp | Compounds |
ATE548044T1 (de) | 2007-05-04 | 2012-03-15 | Vertex Pharma | Kombinationstherapie zur behandlung von hiv- infektionen |
EP2164493A2 (en) * | 2007-05-25 | 2010-03-24 | Janssen Pharmaceutica, N.V. | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
GB0712393D0 (en) * | 2007-06-26 | 2007-08-01 | Smithkline Beecham Corp | Compounds |
US8178699B2 (en) * | 2008-07-30 | 2012-05-15 | Pfizer Inc. | Modulators of CCR9 receptor and methods of use thereof |
BRPI0917719A2 (pt) * | 2008-08-27 | 2019-11-19 | Calcimedica Inc | compostos que modulam cálcio intracelular |
WO2010031832A2 (en) * | 2008-09-18 | 2010-03-25 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc | Synergistic combinations of a macrocyclic inhibitor of hcv and a thiophene-2-carboxylic acid derivative |
EP3025727A1 (en) | 2008-10-02 | 2016-06-01 | The J. David Gladstone Institutes | Methods of treating liver disease |
US8598356B2 (en) * | 2008-11-25 | 2013-12-03 | Janssen Pharmaceutica Nv | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
WO2010068453A1 (en) | 2008-11-25 | 2010-06-17 | Janssen Pharmaceutica Nv | Heteroaryl-substituted urea modulators of fatty acid amide hydrolase |
JP5762971B2 (ja) | 2008-12-03 | 2015-08-12 | プレシディオ ファーマシューティカルズ インコーポレイテッド | Hcvns5aの阻害剤 |
KR20110098779A (ko) | 2008-12-03 | 2011-09-01 | 프레시디오 파마슈티칼스, 인코포레이티드 | Hcv ns5a의 억제제 |
RU2505540C2 (ru) * | 2008-12-23 | 2014-01-27 | Эббви Инк. | Антивирусные соединения |
EP2367823A1 (en) | 2008-12-23 | 2011-09-28 | Abbott Laboratories | Anti-viral compounds |
EP2403860B1 (en) * | 2009-03-04 | 2015-11-04 | IDENIX Pharmaceuticals, Inc. | Phosphothiophene and phosphothiazole as hcv polymerase inhibitors |
US8975247B2 (en) | 2009-03-18 | 2015-03-10 | The Board Of Trustees Of The Leland Stanford Junion University | Methods and compositions of treating a flaviviridae family viral infection |
JP5735482B2 (ja) | 2009-03-27 | 2015-06-17 | プレシディオ ファーマシューティカルズ インコーポレイテッド | 縮合環のc型肝炎阻害剤 |
CN102459165B (zh) * | 2009-04-15 | 2015-09-02 | Abbvie公司 | 抗病毒化合物 |
WO2010141817A1 (en) | 2009-06-05 | 2010-12-09 | Janssen Pharmaceutica Nv | Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase |
US8901111B2 (en) | 2009-06-05 | 2014-12-02 | Janssen Pharmaceutica Nv | Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase |
US8937150B2 (en) | 2009-06-11 | 2015-01-20 | Abbvie Inc. | Anti-viral compounds |
SG10201702522UA (en) * | 2009-06-11 | 2017-05-30 | Abbvie Bahamas Ltd | Anti-viral compounds to treat hcv infection |
ES2427342T3 (es) * | 2009-07-21 | 2013-10-30 | Gilead Sciences, Inc. | Ácidos 5-alquiniltien-2-ilcarboxílicos como inhibidores de virus de los Flaviviridae |
WO2011031669A1 (en) | 2009-09-09 | 2011-03-17 | Gilead Sciences, Inc. | Inhibitors of flaviviridae viruses |
MX2012005528A (es) | 2009-11-14 | 2012-06-12 | Hoffmann La Roche | Biomarcadores para pronosticar rapida respuesta a tratamiento hcv. |
WO2011068715A1 (en) | 2009-11-25 | 2011-06-09 | Vertex Pharmaceuticals Incorporated | 5-alkynyl-thiophene-2-carboxylic acid derivatives and their use for the treatment or prevention of flavivirus infections |
RU2012127201A (ru) | 2009-12-02 | 2014-01-20 | Ф.Хоффманн-Ля Рош Аг | Биомаркеры для прогнозирования устойчивого ответа на лечение вируса гепатита с |
JP2013515746A (ja) | 2009-12-24 | 2013-05-09 | ヴァーテックス ファーマシューティカルズ、 インコーポレイテッド | フラビウイルス感染症の治療又は予防のための類似体 |
JP5777223B2 (ja) | 2010-01-15 | 2015-09-09 | ギリアード サイエンシーズ, インコーポレイテッド | フラビウイルス科ウイルスのインヒビター |
CN102712633B (zh) | 2010-01-15 | 2015-07-29 | 吉里德科学公司 | 黄病毒科病毒的抑制剂 |
KR20120139699A (ko) | 2010-01-29 | 2012-12-27 | 버텍스 파마슈티칼스 인코포레이티드 | C형 간염 바이러스 감염의 치료 요법 |
JP2013522377A (ja) | 2010-03-24 | 2013-06-13 | バーテックス ファーマシューティカルズ インコーポレイテッド | フラビウイルス感染を処置または予防するためのアナログ |
WO2011119853A1 (en) | 2010-03-24 | 2011-09-29 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
TW201141857A (en) | 2010-03-24 | 2011-12-01 | Vertex Pharma | Analogues for the treatment or prevention of flavivirus infections |
EP2550262A1 (en) | 2010-03-24 | 2013-01-30 | Vertex Pharmaceuticals Incorporated | Analogues for the treatment or prevention of flavivirus infections |
UA108233C2 (uk) | 2010-05-03 | 2015-04-10 | Модулятори активності гідролази амідів жирних кислот | |
EP2575866A4 (en) | 2010-05-24 | 2013-10-16 | Presidio Pharmaceuticals Inc | HCV NS5A INHIBITORS |
NZ605440A (en) | 2010-06-10 | 2014-05-30 | Abbvie Bahamas Ltd | Solid compositions comprising an hcv inhibitor |
EP2582717A2 (en) | 2010-06-15 | 2013-04-24 | Vertex Pharmaceuticals Incorporated | Hcv ns5b polymerase mutants |
WO2012006070A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
WO2012006060A1 (en) | 2010-06-28 | 2012-01-12 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
EP2585447A2 (en) | 2010-06-28 | 2013-05-01 | Vertex Pharmaceuticals Incorporated | Compounds and methods for the treatment or prevention of flavivirus infections |
MA34462B1 (fr) * | 2010-07-22 | 2013-08-01 | Novartis Ag | Composes de thiophene 2,3,5- trisubstitues et leurs utilisations |
WO2012020036A1 (en) | 2010-08-13 | 2012-02-16 | F. Hoffmann-La Roche Ag | Hepatitis c virus inhibitors |
CN103153978A (zh) | 2010-08-17 | 2013-06-12 | 沃泰克斯药物股份有限公司 | 用于治疗或预防黄病毒科病毒感染的化合物和方法 |
NZ609564A (en) | 2010-10-26 | 2015-06-26 | Presidio Pharmaceuticals Inc | Inhibitors of hepatitis c virus |
US8771665B2 (en) | 2010-12-17 | 2014-07-08 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis C virus polymerase |
JP6050763B2 (ja) * | 2011-03-03 | 2016-12-21 | デノバメド インク. | 抗菌性の化合物/アジュバント化合物および方法 |
WO2012117097A1 (en) * | 2011-03-03 | 2012-09-07 | Universität des Saarlandes | Biaryl derivatives as selective 17beta-hydroxysteroid dehydrogenase type 2 inhibitors |
WO2012123298A1 (en) | 2011-03-11 | 2012-09-20 | F. Hoffmann-La Roche Ag | Antiviral compounds |
US10201584B1 (en) | 2011-05-17 | 2019-02-12 | Abbvie Inc. | Compositions and methods for treating HCV |
WO2012175581A1 (en) | 2011-06-24 | 2012-12-27 | F. Hoffmann-La Roche Ag | Antiviral compounds |
US8741946B2 (en) | 2011-07-13 | 2014-06-03 | Gilead Sciences, Inc. | Inhibitors of flaviviridae viruses |
WO2013016499A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Methods for preparation of thiophene compounds |
WO2013016491A1 (en) | 2011-07-26 | 2013-01-31 | Vertex Pharmaceuticals Incorporated | Thiophene compounds |
CN103917541B (zh) | 2011-10-10 | 2016-08-17 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒化合物 |
CN103059042B (zh) * | 2011-10-18 | 2015-10-07 | 银杏树药业(苏州)有限公司 | 噻吩类衍生物及其在药学中的用途 |
WO2013086133A1 (en) | 2011-12-06 | 2013-06-13 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for treating viral diseases |
CA2855574A1 (en) | 2011-12-16 | 2013-06-20 | F. Hoffmann-La Roche Ag | Inhibitors of hcv ns5a |
KR101687084B1 (ko) | 2011-12-20 | 2016-12-15 | 리보사이언스 엘엘씨 | Hcv rna 복제의 억제제로서 4'-아지도, 3'-플루오로 치환된 뉴클레오시드 유도체 |
MX350809B (es) | 2011-12-20 | 2017-09-20 | Riboscience Llc | Derivados nucleósidos con sustitución 2',4'-difluoro-2'-metilo como inhibidores de la replicación del arn del vhc. |
US9034832B2 (en) | 2011-12-29 | 2015-05-19 | Abbvie Inc. | Solid compositions |
US9090559B2 (en) | 2012-02-24 | 2015-07-28 | Hoffmann-La Roche Inc. | Antiviral compounds |
WO2013142157A1 (en) | 2012-03-22 | 2013-09-26 | Alios Biopharma, Inc. | Pharmaceutical combinations comprising a thionucleotide analog |
WO2014055142A1 (en) | 2012-06-20 | 2014-04-10 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis c virus polymerase |
US20140010783A1 (en) | 2012-07-06 | 2014-01-09 | Hoffmann-La Roche Inc. | Antiviral compounds |
US8759544B2 (en) | 2012-08-17 | 2014-06-24 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
US8927741B2 (en) | 2012-08-17 | 2015-01-06 | Gilead Sciences, Inc. | Synthesis of an antiviral compound |
US8841340B2 (en) | 2012-08-17 | 2014-09-23 | Gilead Sciences, Inc. | Solid forms of an antiviral compound |
WO2014036443A2 (en) * | 2012-08-31 | 2014-03-06 | Novadrug, Llc | Heterocyclyl carboxamides for treating viral diseases |
CA2892589A1 (en) | 2013-01-23 | 2014-07-31 | F. Hoffmann-La Roche Ag | Antiviral triazole derivatives |
US20150065439A1 (en) | 2013-02-28 | 2015-03-05 | Vertex Pharmaceuticals Incorporated | Pharmaceutical compositions |
CN105008350B (zh) | 2013-03-05 | 2018-05-08 | 弗·哈夫曼-拉罗切有限公司 | 抗病毒化合物 |
US11484534B2 (en) | 2013-03-14 | 2022-11-01 | Abbvie Inc. | Methods for treating HCV |
RU2534613C2 (ru) | 2013-03-22 | 2014-11-27 | Александр Васильевич Иващенко | Алкил 2-{ [(2r,3s,5r)-5-(4-амино-2-оксо-2н-пиримидин-1-ил)- -гидрокси-тетрагидро-фуран-2-илметокси]-фенокси-фосфориламино} -пропионаты, нуклеозидные ингибиторы рнк-полимеразы hcv ns5b, способы их получения и применения |
US20180200280A1 (en) | 2013-05-16 | 2018-07-19 | Riboscience Llc | 4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
US9249176B2 (en) | 2013-05-16 | 2016-02-02 | Riboscience Llc | 4′-azido, 3′-deoxy-3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication |
AU2014265293B2 (en) | 2013-05-16 | 2019-07-18 | Riboscience Llc | 4'-Fluoro-2'-methyl substituted nucleoside derivatives |
EP3089757A1 (en) | 2014-01-03 | 2016-11-09 | AbbVie Inc. | Solid antiviral dosage forms |
MX2016013588A (es) | 2014-04-17 | 2017-01-26 | Merck Sharp & Dohme | Complejo de tanato de sitagliptina. |
EP3166637B1 (en) * | 2014-07-10 | 2020-01-29 | The J. David Gladstone Institutes | Compositions and methods for treating dengue virus infection |
CA2969699A1 (en) * | 2014-12-05 | 2016-06-09 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use |
TWI731854B (zh) | 2015-03-23 | 2021-07-01 | 美商共結晶製藥公司 | C型肝炎病毒聚合酶之抑制劑 |
CN111194217B (zh) | 2017-09-21 | 2024-01-12 | 里伯赛恩斯有限责任公司 | 作为hcv rna复制抑制剂的4’-氟-2’-甲基取代的核苷衍生物 |
EP3759091A1 (en) * | 2018-03-01 | 2021-01-06 | Thomas Helledays stiftelse för medicinsk forskning | Substituted benzodiazoles and use thereof in therapy |
AU2019265740A1 (en) | 2018-05-09 | 2020-10-29 | Cocrystal Pharma, Inc. | Combination therapy for treatment of HCV |
CN108558822B (zh) * | 2018-06-01 | 2020-12-18 | 盐城锦明药业有限公司 | N-((5-溴噻吩-2-基)磺酰基)-2,4-二氯苯甲酰胺的合成方法 |
Family Cites Families (112)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3076817A (en) | 1963-02-05 | New j-amino-thiophene-z | ||
DE1055077B (de) | 1956-02-08 | 1959-04-16 | Bayerische Schrauben Und Feder | Telephonkabelsteckverbinder |
DE1055007B (de) | 1957-08-29 | 1959-04-16 | Dr Hans Fiesselmann | Verfahren zur Herstellung von 3-Aminothiophen-2-carbonsaeureestern und den entsprechenden freien Carbonsaeuren |
US3470151A (en) * | 1966-05-17 | 1969-09-30 | Beecham Group Ltd | Furyl- and thienyl-penicillins and salts thereof |
JPS4811691B1 (cs) | 1967-07-07 | 1973-04-14 | ||
US3823161A (en) | 1970-05-07 | 1974-07-09 | Exxon Research Engineering Co | Aminothiophene derivatives |
US3852293A (en) | 1972-06-21 | 1974-12-03 | Uniroyal Inc | 4-phenyl-2-(3-pyridyl)-thiazole carboxamides |
AU518216B2 (en) | 1977-09-06 | 1981-09-17 | Hafslund Nycomed Pharma Aktiengesellschaft | Thienothiazine derivatives |
DD146952A1 (de) | 1979-11-09 | 1981-03-11 | Karl Gewald | Verfahren zur herstellung von substituierten 3-amino-4-cyan-5-phenylthiophenen |
JPS57116077A (en) | 1981-01-12 | 1982-07-19 | Kanebo Ltd | Thieno(3,2-b)pyridinecarboxylic acid derivative |
US4666502A (en) | 1982-02-09 | 1987-05-19 | Sandoz Ltd. | Herbicidal N-thienyl-chloroacetamides |
EP0103142B1 (de) | 1982-09-09 | 1987-04-22 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Thieno(2,3-e)-1,2-thiazin-Derivate |
GB8515207D0 (en) | 1985-06-15 | 1985-07-17 | Boots Co Plc | Therapeutic agents |
JPS63126884A (ja) | 1986-11-17 | 1988-05-30 | Sankyo Co Ltd | オキサゾロチエノピリミジン誘導体 |
GB8627698D0 (en) * | 1986-11-20 | 1986-12-17 | Boots Co Plc | Therapeutic agents |
DD263055A1 (de) | 1987-07-28 | 1988-12-21 | Univ Dresden Tech | Verfahren zur herstellung substituierter 3-amino-5-phenyl-thiophene |
DE3932052A1 (de) | 1989-09-26 | 1991-04-04 | Basf Ag | Oxazol- bzw. thiazolcarbonsaeureamide |
DE59106349D1 (de) | 1990-06-23 | 1995-10-05 | Basf Ag | Dicarbonsäureimide als Herbizide. |
DE4023048A1 (de) | 1990-07-20 | 1992-01-23 | Basf Ag | Dicarbonsaeureimide, verfahren zu ihrer herstellung und ihre verwendung als herbizide |
JP2574085B2 (ja) | 1991-10-28 | 1997-01-22 | 株式会社トクヤマ | 3−アミノ−2−チオフェンカルボン酸誘導体の製造方法 |
FR2689129B1 (fr) | 1992-03-27 | 1995-05-12 | Atochem Elf Sa | Nouveaux dérivés de l'acide 3-mercapto-2-thénoique et leurs procédés de préparation. |
JPH0625221A (ja) | 1992-07-10 | 1994-02-01 | Tokuyama Soda Co Ltd | 3−アミノ−2−チオフェンカルボン酸誘導体の製造方法 |
DE4244069A1 (de) | 1992-12-24 | 1994-06-30 | Hoechst Ag | Cephalosporinsalze und Verfahren zu deren Herstellung |
JPH0748360A (ja) | 1993-05-31 | 1995-02-21 | Yoshitomi Pharmaceut Ind Ltd | ビフェニルテトラゾール誘導体 |
JPH0718360A (ja) | 1993-07-07 | 1995-01-20 | Sumitomo Light Metal Ind Ltd | 耐摩耗性に優れたTi−Al系金属間化合物部材及びその製造方法 |
EP0658559A1 (de) | 1993-12-14 | 1995-06-21 | Chemisch Pharmazeutische Forschungsgesellschaft m.b.H. | Thienothiazinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als 5-dipoxygenase und Cyclooxygenaseinhibitoren |
KR100423590B1 (ko) | 1995-08-02 | 2004-09-10 | 호따. 우리아치에씨아. 에세. 아. | 항진균활성을갖는신규피리미돈유도체 |
EP0783502A1 (en) | 1995-08-02 | 1997-07-16 | J. URIACH & CIA. S.A. | New carboxamides with antifungal activity |
AU4153497A (en) | 1996-08-26 | 1998-03-19 | Eli Lilly And Company | Combinatorial process for preparing substituted thiophene libraries |
JP4000608B2 (ja) | 1996-11-07 | 2007-10-31 | トヨタ自動車株式会社 | 水素製造充填装置および電気自動車 |
TW523506B (en) * | 1996-12-18 | 2003-03-11 | Ono Pharmaceutical Co | Sulfonamide or carbamide derivatives and drugs containing the same as active ingredients |
US6117911A (en) * | 1997-04-11 | 2000-09-12 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
EE04156B1 (et) | 1997-04-28 | 2003-10-15 | Texas Biotechnology Corporation | Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks |
US6187799B1 (en) | 1997-05-23 | 2001-02-13 | Onyx Pharmaceuticals | Inhibition of raf kinase activity using aryl ureas |
PT1019040E (pt) | 1997-05-23 | 2005-01-31 | Bayer Pharmaceuticals Corp | Inibicao da actividade de p38-quinase por meio de arilureias |
US6344476B1 (en) | 1997-05-23 | 2002-02-05 | Bayer Corporation | Inhibition of p38 kinase activity by aryl ureas |
CA2291065C (en) * | 1997-05-23 | 2010-02-09 | Bayer Corporation | Raf kinase inhibitors |
IL134812A0 (en) | 1997-09-02 | 2001-04-30 | Yoshitomi Pharmaceutical | Condensed thiophene derivatives and pharmaceutical compositions containing the same |
US6140351A (en) | 1997-12-19 | 2000-10-31 | Berlex Laboratories, Inc. | Ortho-anthranilamide derivatives as anti-coagulants |
US20070244120A1 (en) | 2000-08-18 | 2007-10-18 | Jacques Dumas | Inhibition of raf kinase using substituted heterocyclic ureas |
US7329670B1 (en) | 1997-12-22 | 2008-02-12 | Bayer Pharmaceuticals Corporation | Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas |
AU2003204708B2 (en) | 1997-12-22 | 2006-05-25 | Bayer Healthcare Llc | Inhibition of Raf Kinase using Substituted Heterocyclic Ureas |
US6291514B1 (en) | 1998-02-09 | 2001-09-18 | 3-Dimensional Pharmaceuticals, Inc. | Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors |
US20050119332A1 (en) | 1998-03-12 | 2005-06-02 | Lone Jeppesen | Substituted thiophene compounds as modulators of protein tyrosine phosphatases (PTPases) |
US6262044B1 (en) | 1998-03-12 | 2001-07-17 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPASES) |
US6214879B1 (en) | 1998-03-24 | 2001-04-10 | Virginia Commonwealth University | Allosteric inhibitors of pyruvate kinase |
US6147085A (en) * | 1999-04-01 | 2000-11-14 | Neurogen Corporation | Aminoalkyl substituted 9H-pyridino[2,3-b] indole and 9H-pyrimidino[4,5-b] indole derivatives |
US6689754B1 (en) | 1998-04-10 | 2004-02-10 | G. D. Searle & Co. | Heterocyclic glycyl β-alanine derivatives |
PT957099E (pt) | 1998-04-15 | 2003-02-28 | Pfizer Prod Inc | Carboxamidas heterociclicas |
EP0960882A1 (en) * | 1998-05-19 | 1999-12-01 | Hoechst Marion Roussel Deutschland GmbH | Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
US6858223B2 (en) * | 1998-06-23 | 2005-02-22 | Altana Pharma Ag | Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS) |
AU4385399A (en) * | 1998-06-29 | 2000-01-17 | Biochem Pharma Inc. | Thiophene and furan 2,5-dicarboxamides useful in the treatment of cancer |
ES2237966T3 (es) * | 1998-08-20 | 2005-08-01 | Agouron Pharmaceuticals, Inc. | Agentes de gnrh no peptidicos, metodos y compuestos intermedios para su preparacion. |
US7101878B1 (en) | 1998-08-20 | 2006-09-05 | Agouron Pharmaceuticals, Inc. | Non-peptide GNRH agents, methods and intermediates for their preparation |
DE19903398A1 (de) * | 1999-01-29 | 2000-08-10 | Hassan Jomaa | Verwendung von Thiadiazolderivaten zur prophylaktischen und therapeutischen Behandlung von Infektionen |
JP2003529536A (ja) | 1999-02-09 | 2003-10-07 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | C1s介在疾患および状態の処置法、およびそれのための化合物および組成物 |
MXPA01009077A (es) | 1999-03-12 | 2002-03-27 | Boehringer Ingelheim Pharma | Composiciones heterociclicos aromaticos como agentes anti-inflamatorios. |
NZ514711A (en) * | 1999-03-12 | 2004-02-27 | Boehringer Ingelheim Pharma | Compounds useful as anti-inflammatory agents |
JP2001010957A (ja) | 1999-04-28 | 2001-01-16 | Sankyo Co Ltd | 肝障害の予防または抑制剤 |
DE19920247A1 (de) * | 1999-05-03 | 2000-11-16 | Hassan Jomaa | Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung |
HN2000000051A (es) * | 1999-05-19 | 2001-02-02 | Pfizer Prod Inc | Derivados heterociclicos utiles como agentes anticancerosos |
US6867217B1 (en) | 1999-05-19 | 2005-03-15 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
GB9929552D0 (en) | 1999-12-14 | 2000-02-09 | Proteus Molecular Design | Compounds |
EP1229010A1 (en) | 1999-10-01 | 2002-08-07 | Japan Energy Corporation | Novel diarylamide derivatives and use thereof as medicines |
CN1384826A (zh) * | 1999-11-29 | 2002-12-11 | 诺瓦提斯公司 | 作为农药的N-杂芳基-α-烷氧亚氨基羧酸酰胺 |
DE10002424A1 (de) * | 2000-01-20 | 2001-07-26 | Siemens Ag | Di(het)arylaminothiophen-Derivate |
GB0003154D0 (en) | 2000-02-12 | 2000-04-05 | Astrazeneca Uk Ltd | Novel compounds |
MY138097A (en) | 2000-03-22 | 2009-04-30 | Du Pont | Insecticidal anthranilamides |
JP2001354658A (ja) | 2000-06-15 | 2001-12-25 | Taisho Pharmaceut Co Ltd | ヒドロキシホルムアミジン化合物及びその塩並びにそれらを含む医薬 |
US6414013B1 (en) * | 2000-06-19 | 2002-07-02 | Pharmacia & Upjohn S.P.A. | Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
WO2002028353A2 (en) | 2000-10-05 | 2002-04-11 | Smithkline Beecham Corporation | Phosphate transport inhibitors |
CA2426033A1 (en) | 2000-11-08 | 2002-05-16 | Syngenta Participations Ag | Pyrrolcarboxamides and pyrrolcarbothioamides and their agrochemical uses |
US7015223B1 (en) | 2000-11-20 | 2006-03-21 | Pharmacia Corporation | Substituted polycyclic aryl and heteroaryl 1,2,4-triazinones useful for selective inhibition of the coagulation cascade |
US6892279B2 (en) * | 2000-11-30 | 2005-05-10 | Mosaid Technologies Incorporated | Method and apparatus for accelerating retrieval of data from a memory system with cache by reducing latency |
DE10061876A1 (de) | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
CA2433778A1 (en) | 2001-02-14 | 2002-08-22 | William Glen Harter | Thieno'2,3-d pyrimidindione derivatives as matrix metalloproteinase inhibitors |
EP1975620A3 (en) | 2001-03-02 | 2008-12-24 | GPC Biotech AG | Three hybrid assay system |
US20040102324A1 (en) | 2002-02-28 | 2004-05-27 | Annis Gary David | Heterocyclic diamide invertebrate pest control agents |
IL157845A0 (en) | 2001-03-13 | 2004-03-28 | Univ Kingston | Anti-epileptogenic agents |
US6734207B2 (en) * | 2001-04-20 | 2004-05-11 | Parker Hughes Institute | Cytotoxic compounds |
US6713638B2 (en) * | 2001-05-18 | 2004-03-30 | Joel M. Linden | 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
EP1395571A1 (en) | 2001-06-11 | 2004-03-10 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
AP1753A (en) | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
SE0102617D0 (sv) * | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
SE0102616D0 (sv) | 2001-07-25 | 2001-07-25 | Astrazeneca Ab | Novel compounds |
JP2003073357A (ja) | 2001-09-03 | 2003-03-12 | Mitsubishi Pharma Corp | アミド化合物を含有するRhoキナーゼ阻害剤 |
US6924276B2 (en) | 2001-09-10 | 2005-08-02 | Warner-Lambert Company | Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors |
WO2003029242A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | NF-λB INHIBITORS |
US7285557B2 (en) | 2001-10-15 | 2007-10-23 | Smithkline Beecham P.L.C. | Pyrimidinones as melanin concentrating hormone receptor 1 |
US7220777B2 (en) | 2001-10-15 | 2007-05-22 | Smithkline Beecham P.L.C. | Lactam derivatives as antagonists for human 11cby receptors |
TWI281916B (en) * | 2001-10-25 | 2007-06-01 | Lilly Co Eli | Antitumor compounds and methods |
AU2002352443A1 (en) * | 2001-12-21 | 2003-07-15 | Consejo Superior De Investigaciones Cientificas | Compounds and their therapeutic use related to the phosphorylating activity of the enzyme gsk-3 |
US6835745B2 (en) * | 2002-01-15 | 2004-12-28 | Wyeth | Phenyl substituted thiophenes as estrogenic agents |
WO2003068223A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Corporation | Aryl ureas with raf kinase and angiogenesis inhibiting activity |
US20030220336A1 (en) | 2002-04-05 | 2003-11-27 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method of treating mucus hypersecretion |
JP2005538953A (ja) * | 2002-05-28 | 2005-12-22 | 3−ディメンショナル ファーマシューティカルズ, インコーポレイテッド | 新規チオフェンアミジン、それらの組成物、および補体媒介疾患および病気を治療する方法 |
CN1155679C (zh) | 2002-09-20 | 2004-06-30 | 华南理工大学 | 含低聚噻吩骨格的液晶化合物及其制备方法 |
US7179836B2 (en) * | 2002-09-20 | 2007-02-20 | Smithkline Beecham Corporation | Chemical compounds |
BR0315580A (pt) | 2002-10-24 | 2005-08-30 | Merck Patent Gmbh | Derivados de metileno uréia |
US20050075331A1 (en) | 2003-10-06 | 2005-04-07 | Pratt John K. | Anti-infective agents |
CA2504385C (en) | 2002-11-01 | 2012-12-18 | Abbott Laboratories | Thiadiazine compounds and uses thereof |
US20040097492A1 (en) | 2002-11-01 | 2004-05-20 | Pratt John K | Anti-infective agents |
US7902203B2 (en) | 2002-11-01 | 2011-03-08 | Abbott Laboratories, Inc. | Anti-infective agents |
US20040162285A1 (en) | 2002-11-01 | 2004-08-19 | Pratt John K. | Anti-infective agents |
KR101058696B1 (ko) | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
US20040192707A1 (en) | 2002-12-10 | 2004-09-30 | Laval Chan Chun Kong | Compounds and methods for the treatment or prevention of Flavivirus infections |
TW200418825A (en) * | 2002-12-16 | 2004-10-01 | Hoffmann La Roche | Novel (R)-and (S) enantiomers of thiophene hydroxamic acid derivatives |
DE10359791A1 (de) | 2003-12-19 | 2005-07-21 | Bayer Healthcare Ag | Substituierte Thiophene |
US7470701B2 (en) | 2004-03-30 | 2008-12-30 | Novartis Vaccines And Diagnostics, Inc. | Substituted 2,5-heterocyclic derivatives |
DE102005028077A1 (de) | 2004-12-22 | 2006-07-13 | Aicuris Gmbh & Co. Kg | Alkinyl-substituierte Thiophene |
ES2415742T3 (es) * | 2005-05-13 | 2013-07-26 | Vertex Pharmaceuticals (Canada) Incorporated | Compuestos y procedimientos para el tratamiento o prevención de infecciones por flavivirus |
-
2002
- 2002-06-11 AP APAP/P/2003/002932A patent/AP1753A/en active
- 2002-06-11 WO PCT/CA2002/000876 patent/WO2002100851A2/en active Application Filing
- 2002-06-11 KR KR1020037016240A patent/KR100900304B1/ko not_active IP Right Cessation
- 2002-06-11 CN CNB028157680A patent/CN100509797C/zh not_active Expired - Fee Related
- 2002-06-11 CA CA2450007A patent/CA2450007C/en not_active Expired - Fee Related
- 2002-06-11 AU AU2002344854A patent/AU2002344854B2/en not_active Ceased
- 2002-06-11 EP EP02742563A patent/EP1401825B1/en not_active Expired - Lifetime
- 2002-06-11 AT AT02742563T patent/ATE438637T1/de active
- 2002-06-11 ES ES02742563T patent/ES2330313T3/es not_active Expired - Lifetime
- 2002-06-11 US US10/166,031 patent/US6881741B2/en not_active Expired - Fee Related
- 2002-06-11 CN CN200910139375A patent/CN101624391A/zh active Pending
- 2002-06-11 PL PL367080A patent/PL208713B1/pl not_active IP Right Cessation
- 2002-06-11 SK SK1520-2003A patent/SK288015B6/sk not_active IP Right Cessation
- 2002-06-11 DE DE60233227T patent/DE60233227D1/de not_active Expired - Lifetime
- 2002-06-11 BR BR0210357-5A patent/BR0210357A/pt not_active IP Right Cessation
- 2002-06-11 DK DK02742563T patent/DK1401825T3/da active
- 2002-06-11 PT PT02742563T patent/PT1401825E/pt unknown
- 2002-06-11 EP EP10185737A patent/EP2363396A1/en not_active Withdrawn
- 2002-06-11 JP JP2003503618A patent/JP4544857B2/ja not_active Expired - Fee Related
- 2002-06-11 EA EA200400022A patent/EA007484B1/ru not_active IP Right Cessation
- 2002-06-11 MX MXPA03011452A patent/MXPA03011452A/es active IP Right Grant
- 2002-06-11 PL PL395097A patent/PL395097A1/pl unknown
- 2002-06-11 OA OA1200300320A patent/OA12622A/en unknown
- 2002-06-11 SI SI200230851T patent/SI1401825T1/sl unknown
- 2002-06-11 CZ CZ20033368A patent/CZ20033368A3/cs unknown
- 2002-06-11 EP EP09167203A patent/EP2206709A3/en not_active Withdrawn
-
2003
- 2003-12-10 NO NO20035485A patent/NO331721B1/no not_active IP Right Cessation
- 2003-12-10 ZA ZA200309590A patent/ZA200309590B/en unknown
-
2005
- 2005-01-26 US US11/042,442 patent/US7985769B2/en not_active Expired - Fee Related
-
2009
- 2009-02-05 AU AU2009200430A patent/AU2009200430B2/en not_active Ceased
- 2009-10-22 CY CY20091101100T patent/CY1109497T1/el unknown
-
2010
- 2010-04-28 JP JP2010103706A patent/JP5412370B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200309590B (en) | Thiophene derivatives as antiviral agents for flavivirus infection. | |
JP2005500288A5 (cs) | ||
JP5777223B2 (ja) | フラビウイルス科ウイルスのインヒビター | |
KR101727776B1 (ko) | 플라비비리다에 바이러스의 억제제 | |
JP2008540463A5 (cs) | ||
US20080039377A1 (en) | Composition Comprising a Jnk Inhibitor and Cyclosporin | |
CA2508990A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
CA2607359A1 (en) | Compounds and methods for the treatment or prevention of flavivirus infections | |
WO2004066987B1 (en) | Use of sodium channel modulators for treating gastrointestinal tract disorders | |
ZA200503501B (en) | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases | |
PT2507249E (pt) | Inibidores de vírus flaviviridae | |
WO2002028353A2 (en) | Phosphate transport inhibitors | |
EP1746888A2 (en) | Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases | |
US20090176762A1 (en) | JNK Inhibitors for Treatment of Skin Diseases | |
CN103153978A (zh) | 用于治疗或预防黄病毒科病毒感染的化合物和方法 | |
US8329924B2 (en) | Compounds and methods for the treatment or prevention of Flavivirus infections | |
ZA200502752B (en) | 1,4-Disubstituted piperidine derivatives and theiruse as 11-betaHSD1 inhibitors. | |
KR20130087052A (ko) | 자궁내막증 치료 및 예방용 jnk 억제제 |